pharmac
ther
vol
pp
pergamon
press
ltd
print
interferon
group
protein
produc
eucaryot
cell
stimul
viru
infect
doublestrand
rna
variou
induc
cell
treat
interferon
exhibit
number
respons
princip
action
interest
review
establish
viru
resist
howev
number
respons
describ
inhibit
nonvir
agent
prime
block
cellmultiplicationinhibit
toxic
enhanc
enhanc
synthet
activ
surfac
alter
enhanc
immunolysi
enhanc
phagocytosi
variou
immun
modul
survey
first
discuss
antivir
action
interferon
vitro
vivo
describ
nonantivir
activ
like
contribut
viru
resist
mechan
anim
antivir
action
interferon
cellular
genet
control
interferon
must
induc
new
cellular
messeng
rna
protein
synthesi
cell
becom
resist
virus
lockart
taylor
cell
nucleu
must
present
time
interferon
treatment
afterward
radk
et
al
young
et
al
difficulti
genet
analys
interferon
action
first
overcom
use
somat
cell
hybrid
human
mous
cell
littl
crossspeci
activ
interferon
produc
humanmous
cell
hybrid
produc
fusion
two
cell
type
use
inactiv
sendal
viru
hybrid
preferenti
lose
human
chromosom
human
phenotyp
thu
possibl
correl
loss
human
phenotyp
concomit
loss
particular
human
chromosom
result
experi
enabl
gene
dosag
genet
experi
perform
aneuploid
cell
abnorm
number
certain
chromosom
must
emphas
numer
epigenet
factor
contribut
modul
sensit
interferon
andor
abil
cell
express
antivir
nonantivir
activ
epigenet
factor
exert
modul
capac
stage
bind
interferon
cell
surfac
translat
antivir
protein
express
thu
action
mechan
interferon
best
understood
breakdown
step
action
analysi
data
pertain
step
use
monkeymous
cell
hybrid
chani
associ
cassingena
et
al
chani
et
al
chani
et
al
chani
show
gene
product
action
interferon
asynten
mice
present
chromosom
also
found
case
human
interferon
system
tan
et
al
tan
et
al
tan
colleagu
use
larg
number
humanmous
hybrid
cell
gradual
lost
human
chromosom
retain
mous
chromosom
demonstr
correl
residu
human
chromosom
sensit
antivir
activ
human
interferon
posit
correl
found
sensit
human
interferon
express
human
isozym
indophenolozidas
presenc
human
chromosom
observ
confirm
number
subclon
indophenolozidas
human
antivir
action
segreg
concomitantli
tan
et
al
tan
cregan
et
al
morgan
faik
found
phenomenon
use
humanhamst
hybrid
human
interferon
antivir
activ
depend
presenc
human
chromosom
revel
et
al
confirm
involv
human
chromosom
antivir
activ
human
interferon
use
humanmous
hybrid
chani
et
al
claim
human
chromosom
present
humanmous
hybrid
respons
human
interferon
respons
depend
upon
presenc
human
chromosom
hybrid
well
chani
howev
slate
et
al
found
mere
presenc
human
chromosom
suffici
elicit
antivir
respons
human
interferon
wherea
presenc
human
chromosom
hybrid
elev
sensit
human
interferon
assign
human
interferon
antivir
activ
chromosom
confirm
number
studi
use
cell
contain
abnorm
copi
specif
chromosom
human
cell
genet
disord
syndrom
trisom
common
tan
et
al
found
sensit
human
interferon
exhibit
hierarchi
correspond
number
chromosom
ie
trisomi
normal
diploid
monosom
aneuploid
cell
observ
confirm
repeatedli
number
laboratori
tan
et
al
tan
revel
et
al
wiranowskastewart
stewart
ii
slate
et
al
trisom
human
cell
line
routin
use
human
interferon
assay
numer
laboratori
higher
sensit
relationship
interferon
sensit
number
chromosom
also
extend
antivir
action
induc
human
type
ii
interferon
human
leukocyt
interferon
human
fibroblast
interferon
slate
et
al
wiranowskastewart
stewart
ii
molecular
sizeform
human
leukocyt
interferon
isol
sdspolyacrylamid
gel
stewart
ii
et
al
hierarchi
found
exist
human
cell
expos
mous
heterolog
interferon
wiranowska
stewart
stewart
ii
shown
increas
sensit
specif
respons
increas
number
chromosom
cell
loss
gain
human
chromosom
exhibit
increas
decreas
sensit
epstein
epstein
furthermor
least
two
separ
laboratori
abl
local
interferon
sensit
gene
distal
portion
long
arm
human
chromosom
tan
green
epstein
epstein
oppos
claim
relationship
human
chromosom
sensit
nonantivir
activ
interferon
declercq
et
al
claim
correl
antivir
doublestrand
rna
toxic
enhanc
prime
activ
interferon
human
cell
monosom
disom
trisom
chromosom
thu
conclud
nonantivir
activ
interferon
control
chromosom
sever
worker
shown
result
contrari
tan
shown
sensit
cell
cellmultiplicationinhibitori
action
interferon
control
chromosom
cuppl
tan
demonstr
chromosom
determin
sensit
inhibit
mitogeninduc
lymphoblastogenesi
human
interferon
frankfort
et
al
recent
demonstr
prime
activ
interferon
control
human
chromosom
view
amount
data
support
correl
nonantivir
activ
interferon
chromosom
conclud
declercq
associ
might
er
interpret
observ
increas
sensit
interferon
increas
exponenti
increas
number
chromosom
linearli
wiranowskastewart
stewart
ii
therefor
possibl
regulatori
genet
control
interferon
action
locat
separ
chromosom
increas
chromosom
creat
imbal
product
action
gene
regul
chani
et
al
show
human
tripioid
cell
normal
respons
interferon
suggest
full
complement
chromosom
offset
increas
sensit
interferon
confer
increas
number
chromosom
investig
also
found
human
cell
trisom
chromosom
less
sensit
normal
diploid
cell
human
interferon
suggest
regulatori
control
interferon
sensit
might
chromosom
blacholszewska
et
al
postul
disproportion
number
regulatori
chromosom
hela
cell
make
cell
line
insensit
interferon
previou
section
present
data
show
increas
sensit
human
interferon
antivir
nonantivir
action
determin
chromosom
present
data
show
increas
sensit
due
interferon
receptor
compon
code
chromosom
exact
natur
initi
interact
interferon
cell
remain
unknown
suggest
membran
compon
bind
interferon
exact
mode
bind
remain
specul
shown
number
laboratori
interferon
capabl
strong
highli
select
adsorpt
number
unrel
substanc
includ
protein
simpl
hydrocarbon
polyribonucleotid
thu
simpl
task
determin
receptor
compon
cell
surfac
interfer
simpl
bind
studi
isol
compon
indirect
studi
earli
attempt
demonstr
bind
interferon
cell
measur
decreas
interferon
medium
conflict
investig
found
interferon
activ
disappear
medium
cell
contact
burk
buchan
gifford
lindenmann
et
al
merigan
seller
fitzpatrick
wagner
howev
loss
could
attribut
inactiv
interferon
merigan
et
al
adhes
variou
surfac
lampson
et
al
investig
report
interferon
could
repeatedli
induc
antivir
activ
cultur
without
appreci
loss
activ
friedman
also
found
interferoninduc
resist
cell
bind
cold
remov
wash
howev
treatment
cell
trypsin
exposur
interferon
cold
prevent
develop
interferoninduc
viru
resist
friedman
goldsbi
levin
vilcek
lowi
berman
vilcek
data
suggest
interferon
first
bind
cell
superfici
site
report
interferon
treatment
cell
alter
subsequ
bind
cell
cholera
toxin
thyrotropin
interferontr
cell
also
less
sensit
toxic
diphtheria
toxin
yabrov
j
data
suggest
either
interferon
share
receptor
site
cholera
toxin
diphtheria
toxin
thyrotropin
interferon
bind
alter
cell
membran
way
decreas
bind
substanc
data
knight
korant
demonstr
interferontr
cell
electrophoret
differ
normal
cell
tend
support
hypothesi
interferon
bind
induc
cell
alter
gangliosid
suggest
play
role
receptor
receptorlik
bind
interferon
receptor
infer
gangliosid
gangliosidelik
structur
receptoractiv
gangliosideglycoprotein
complex
ankel
vengri
et
al
pitha
et
al
kohn
et
al
pitha
friedman
gangliosid
also
report
abl
coat
interferon
bound
agaros
convers
gangliosid
bound
agaros
abl
bind
interferon
besancon
ankel
besancon
et
al
besancon
ankel
also
report
pretreat
cell
plant
lectin
block
action
interferon
addit
gangliosid
certain
mous
cell
defici
structur
increas
sensit
interferon
pitha
et
al
interpret
data
difficult
view
known
hostrang
specif
interferon
affin
exhibit
interferon
numer
structur
unrel
substanc
eg
polyribonucleotid
blue
dextran
glass
bead
immobil
ltryptophan
etc
interferon
immobil
agaros
bead
use
demonstr
induct
antivir
ankel
et
al
chani
et
al
knight
nonantivir
knight
activ
trigger
exterior
cell
rather
tenuou
sinc
imposs
exclud
possibl
interferon
leakag
agaros
bead
remov
interferon
agaros
bead
cell
contact
direct
studi
posit
correl
sensit
cell
interferon
amount
interferon
bound
cell
surfac
sensit
level
determin
number
interferon
receptor
cell
surfac
wagner
unabl
recov
detect
antivir
activ
treat
chick
cell
unit
interferon
levin
also
unabl
detect
interferon
activ
treat
cell
unit
interferon
abl
detect
unit
cell
treat
unit
interferon
friedman
also
abl
recov
trace
level
antivir
activ
chick
cell
treat
unitsml
interferon
howev
attempt
made
correl
bind
sensit
cell
interferon
bound
stewart
ii
et
al
found
mous
interferon
could
recov
mous
ceil
treat
mous
interferon
unabl
detect
antivir
activ
heterolog
cell
treat
mous
interferon
amount
interferon
recov
three
differ
type
mous
cell
correl
directli
sensit
exhibit
antivir
activ
interferon
mous
interferon
found
bind
cell
though
slower
kinet
lower
temperatur
interferon
bound
sensit
trypsin
treatment
wherea
interferon
bind
higher
temperatur
insensit
trypsin
digest
use
human
interferon
berman
vilcek
confirm
observ
interferon
could
recov
heterolog
cell
homolog
cell
interferon
bind
cell
interferon
bind
remain
sensit
treatment
trypsin
wherea
bind
also
found
appli
interferon
rapidli
becam
intern
cellsap
nuclear
membran
fragment
known
howev
uptak
interferon
necessari
activ
induc
kohno
et
al
b
found
cellbound
interferon
elut
cell
remov
unbound
interferon
later
report
bind
interferon
cell
determin
antivir
activ
use
two
rodent
interferon
mous
hamster
varieti
rodent
cell
line
umino
khomo
gresser
et
al
found
murin
leukemia
cell
resist
antivir
cellmultiplicationinhibitori
action
interferon
bind
mous
interferon
wherea
cell
sensit
action
interferon
bind
mous
interferon
cell
later
found
resist
sensit
respect
doublestrand
rna
toxicityenhanc
effect
interferon
werenn
rousseau
gresser
stewart
ii
unpublish
data
certain
instanc
bind
interferon
correl
subsequ
induct
interferon
action
chani
vignal
describ
mous
embryo
line
transform
murin
sarcoma
viru
becam
complet
resist
antivir
action
interferon
passag
continu
presenc
interferon
cell
found
bind
interferon
extent
parent
interferonsensit
mous
cell
stewart
ii
unpublish
data
kuwata
cowork
kuwata
et
al
b
fuse
kuwata
describ
two
line
transform
human
cell
sensit
antivir
effect
interferon
differ
sensit
cellmultiplicationinhibitori
action
interferon
cell
resist
effect
bound
appreci
less
amount
interferon
cell
sensit
cellmultiplicationinhibit
action
interferon
report
suggest
control
mechan
subsequ
bind
interferon
also
affect
action
interferon
number
propos
role
chromosom
sensit
interferon
action
tan
suggest
chromosom
code
synthesi
intracellular
antivir
protein
chani
et
al
revel
et
al
suggest
chromosom
carri
structur
gene
human
interferon
receptor
base
observ
cell
sensit
interferon
becam
resist
treat
antiserum
prepar
chromosom
cell
surfac
compon
chani
colleagu
chani
suggest
interferon
hostspecif
due
interferonreceptor
interact
determin
chromosom
human
cell
wherea
humanmous
hybrid
receptor
human
origin
antivir
machineri
mous
origin
slate
et
al
shown
humanmous
hybrid
contain
human
chromosom
detect
human
genet
compon
sensit
human
interferon
fibroblast
leukocyt
antivir
mechan
due
mous
chromosomedirect
product
data
indic
human
chromosom
code
interferon
receptor
declercq
et
al
claim
cell
differ
number
copi
chromosom
tri
di
monosom
addit
equal
sensit
nonantivir
action
interferon
abl
bind
amount
human
interferon
claim
howev
refut
wiranowska
stewart
stewart
ii
fourid
human
cell
one
two
three
copi
human
chromosom
bound
increas
amount
interferon
action
interferon
modul
factor
genet
influenc
specif
chromosom
event
subsequ
interferon
bind
transcript
translat
affect
give
alter
interferoninduc
product
complic
contribut
difficulti
understand
action
interferon
assign
genet
element
control
action
tissu
young
chick
embryo
much
less
sensit
interferon
tissu
older
embryo
isaac
baron
cantel
et
al
grossberg
morahan
similar
differ
found
human
embryon
tissu
siewer
et
al
sever
laboratori
found
cultur
cell
line
exhibit
differ
sensit
interferon
cultur
differ
age
compar
older
cultur
sensit
cantel
paucker
carver
marcu
lockart
lockart
rossman
vilcek
billiau
buckler
mclaren
korsantiya
et
al
lvovski
levi
differ
sensit
rang
tenfold
differ
clearli
due
genet
differ
least
three
mechan
suggest
account
age
effect
interferon
sensit
cell
may
continu
accumul
interferon
receptor
age
henc
cell
surfac
becom
increasingli
satur
receptor
molecul
direct
evid
possibl
effort
made
perform
bind
experi
fix
number
cell
similar
cultur
age
wiranowska
stewart
stewart
ii
b
younger
cell
may
repressor
interferon
action
sever
report
substanc
appear
literatur
refer
variou
name
stimulon
chani
brailovski
brailovski
chani
interferon
antagonist
truden
et
id
fournier
et
al
fournier
et
al
fournier
et
al
rytel
lidin
adam
cembrzynskanowak
grossberg
morahan
report
younger
cell
elabor
type
factor
ad
older
cell
antagonist
interferon
action
c
younger
cell
may
abl
inactiv
interferon
korsantiya
et
al
rossman
vilcek
report
interferon
sensit
influenc
cell
densiti
dianzani
colleagu
demonstr
antivir
resist
develop
rapidli
higher
level
concentr
cultur
could
due
higher
level
local
interferon
transfer
one
cell
anoth
cell
pack
closer
dianzani
et
al
baron
blalock
baron
recent
report
interferontr
cell
appar
elabor
part
antivir
machineri
could
transfer
one
cell
anoth
feasibl
dens
cultur
could
better
transfer
antivir
machineri
adjac
cell
via
effici
cellcel
inform
transfer
variat
even
among
diploid
human
cell
respect
sensit
interferon
j
gifford
report
mous
spleen
cell
time
less
sensit
antivir
effect
mous
interferon
cell
turn
somewhat
less
sensit
primari
mous
embryo
fibroblast
mous
kidney
cultur
demaeyerguignard
et
al
stewart
ii
et
al
number
factor
report
influenc
appar
sensit
cell
interferon
discuss
emphas
difficulti
unravel
genet
compon
respons
interferon
action
mechan
variabl
must
consid
care
control
experi
design
understand
mechan
action
interferon
number
factor
report
inhibitori
action
interferon
factor
assum
stimul
viru
growth
subsequ
shown
enhanc
viru
growth
decreas
interferon
product
kato
egger
kato
ohta
kato
et
al
kato
et
al
b
kato
et
al
factor
shown
enhanc
viru
growth
stimul
mechan
total
unrel
interferon
action
chani
associ
describ
protein
isol
virusinfect
uninfect
tissu
ad
cell
interferon
treatment
lower
viru
resist
tissu
brailovski
chani
chani
brailovski
chani
et
al
galliot
et
al
fournier
et
al
fournier
et
al
fournier
et
al
fournier
et
al
chanyfourni
et
al
laboratori
similarli
isol
factor
variou
sourc
ghendon
ghendon
et
al
truden
et
al
brodeur
et
al
rytel
cembrzynskanowak
recent
chani
cowork
report
plant
lectin
elimin
antivir
state
establish
interferon
treatment
suggest
tissu
antagonist
interferon
mammalian
lectinlik
substanc
pauloin
et
al
factor
known
alter
cell
surfac
structur
integr
cell
membran
shown
chang
cellular
respons
interferon
alter
presum
due
alter
interferon
bind
andor
activ
event
subsequ
interferoncel
contact
chani
bourgead
chani
variou
substanc
affin
gangliosid
gangliosid
shown
affect
interferon
sensit
cell
sinc
rather
gener
phenomenon
specif
cell
origin
assum
substanc
lower
interferon
adhes
cell
surfac
rather
affect
specif
interferon
receptor
besancon
ankel
besancon
et
al
vengri
et
al
friedman
kohn
shown
cholera
toxin
capabl
inhibit
develop
antivir
activ
toxin
ad
time
interferon
howev
effect
toxin
ad
interferon
treatment
similar
effect
demonstr
gonadotropin
besancon
ankel
thyrotropin
kohn
et
al
find
suggest
twostep
bindinginiti
event
mutual
exclus
bind
substanc
interferon
cell
surfac
isoprinosin
paraacetanidobenzo
acid
salt
n
agent
affect
cell
membran
report
increas
antivir
potenc
interferon
mice
activ
vitro
chani
cerutti
b
cytochalasin
b
colchicin
vinblastin
affect
microtubul
microfila
develop
cell
shown
decreas
action
interferon
soloviev
mentkevich
bourgead
chani
chemic
demonstr
inhibit
action
interferon
ouabain
inhibitor
membran
adenosin
triphosphatas
lebon
et
al
mercaptopyridethylbenzimidazol
inhibitor
nucleosid
transport
across
cell
membran
friedman
pastan
vitamin
blalock
gifford
appar
direct
inactiv
interferon
vitamin
blalock
gifford
agent
report
enhanc
interferon
action
dibazol
benzimidazol
deriv
yabrov
et
al
polylornithin
increas
adsorpt
uptak
macromolecul
cell
kleinschmidt
elli
till
histon
stancek
matisova
extract
escherichia
coli
vilcek
ng
steroid
hormon
unknown
mechan
report
enhanc
affect
decreas
interferon
action
kilbourn
et
al
reinick
reinick
mendelson
glasgow
demaey
demaey
evid
list
agent
exhibit
effect
interferon
action
wide
vari
common
trend
probabl
act
differ
mechan
remain
elucid
temperatur
appar
effect
action
interferon
within
rang
gifford
ruizgomez
isaac
stewart
ii
desmyt
unpublish
data
b
oxygen
tension
report
effect
oxygen
tension
interferon
action
contradictori
isaac
et
al
report
oxygen
tension
influenc
interferon
action
wherea
investig
unabl
determin
effect
gifford
burk
buchan
zemla
sehramek
c
ph
contradictori
claim
respect
effect
ph
interferon
action
gifford
burk
buchan
report
effect
ph
chang
interferon
titer
rang
ph
demaey
desom
report
lower
bicarbon
concentr
gave
elev
interferon
titer
hallum
et
al
found
ph
interferon
unabl
induc
viru
resist
suggest
could
due
dissoci
polysom
brown
besancon
brown
et
al
also
found
inhibitori
effect
ph
interferon
action
attribut
membran
transport
arrest
rather
sole
inhibit
cellular
metabol
ion
heavi
metal
gainer
report
high
concentr
arsen
ad
cultur
shortli
interferon
treatment
inhibit
interferon
action
wherea
low
concentr
ion
increas
activ
interferon
also
report
near
toxic
concentr
cadmium
mercur
nickel
salt
reduc
action
interferon
cell
cultur
e
cyclic
amp
friedman
pastan
report
cyclic
amp
slightli
increas
sensit
chick
cell
interferon
effect
observ
sever
analog
cyclic
amp
allen
et
al
report
twofold
increas
interferon
action
mous
cell
relat
cyclic
nucleotid
pronounc
effect
cyclic
phosphat
concentr
increas
interferon
action
sixteento
thirtytwofold
suggest
cyclic
nucleotid
affect
cell
behav
age
cultur
weber
stewart
also
report
vitamin
c
slightli
enhanc
antivir
activ
human
leukocyt
interferon
human
fibroblast
cell
suggest
increas
due
elev
product
cyclic
amp
meldolesi
et
al
demonstr
interferon
induc
increas
cyclic
amp
level
interferonsensit
ceil
interferonresist
cell
elev
cyclic
amp
preced
induct
antivir
activ
mec
et
al
report
interferon
elev
level
cyclic
amp
l
cell
increas
parallel
antivir
activ
f
virus
variou
investig
report
number
virus
capabl
abort
effect
interferon
cell
cultur
variou
anim
includ
calf
kidney
cultur
infect
parainfluenza
viru
hermodsson
hermodsson
newborn
calf
kidney
cultur
infect
bovin
diarrhea
viru
diderholm
dinter
chick
cell
infect
mump
viru
frothingham
chick
cell
infect
tickborn
enceph
viru
libikova
l
cell
infect
tickborn
enceph
viru
vilcek
stancek
hela
cell
infect
sendai
viru
maeno
et
al
suggest
mechan
wherebi
growth
one
viru
enhanc
growth
anoth
paucker
henl
cantel
thacor
cowork
also
abl
demonstr
one
viru
rescu
anoth
interferoninduc
inhibit
thacor
youngner
thacor
view
number
complic
contribut
variou
factor
affect
viru
infect
growth
interferontr
cell
possibl
attribut
mani
fluctuat
interferon
respons
genet
determin
treat
cell
easi
task
investig
particular
genet
influenc
interferon
action
antivir
activ
interferon
treat
cellular
level
molecular
level
nonantivir
activ
interferon
discuss
antivir
activ
interferon
intact
anim
consid
last
seem
like
action
interferon
host
recoveri
process
viru
infect
involv
antivir
nonantivir
activ
antivir
activ
interferon
cell
examin
extens
antivir
activ
result
nonspecif
toxic
effect
cell
rather
inhibit
replic
wide
rang
virus
process
requir
de
novo
cellular
protein
synthesi
initi
interact
cell
interferon
essenti
subsequ
develop
viru
resist
establish
antivir
state
achiev
slowli
sever
hour
though
interferonbind
complet
within
minut
berman
vilcek
antivir
state
establish
maintain
sever
hour
sever
day
depend
variabl
physiolog
state
cell
cell
return
previou
virussensit
state
section
describ
event
bind
interferon
cell
develop
antivir
state
mechan
interferon
exert
inhibitori
effect
virus
decay
antivir
state
lindenmann
et
al
observ
detect
develop
viru
resist
chick
cell
expos
interferon
viru
simultan
viru
resist
found
cell
expos
interferon
hr
viru
infect
maxim
resist
viru
infect
found
cell
expos
interferon
hr
investig
found
short
treatment
interferon
often
inhibit
viru
replic
vilcek
other
found
inhibit
interferon
treatment
even
interferon
ad
viru
exposur
wagner
desom
et
al
grossberg
holland
lerner
bailey
howev
usual
sever
hour
exposur
incub
initi
treatment
interferon
necessari
develop
full
antivir
activ
time
requir
exposur
interferon
full
establish
antivir
state
cell
found
sever
investig
independ
interferon
concentr
use
induct
viral
resist
lockart
baron
et
al
respons
rate
develop
resist
sever
virus
interferontr
chick
cell
found
howev
develop
resist
virus
slower
interferontr
mous
cell
jordan
dianzani
et
al
report
strain
human
foreskin
cell
viral
resist
reach
maximum
hr
exposur
interferon
unitsml
wherea
human
fibroblast
develop
maximum
resist
hr
interferon
treatment
recent
dianzani
associ
dianzani
et
al
baron
investig
effect
high
concentr
local
interferon
develop
viru
resist
found
drastic
differ
cellular
respons
interferon
prepar
kept
differ
temperatur
name
prewarm
interferon
prepar
interferon
prepar
kept
room
temperatur
antivir
resist
develop
fulli
within
minut
cell
treat
prewarm
interferon
prepar
wherea
lower
temperatur
interferon
prepar
sever
hour
requir
cell
treat
warm
interferon
min
develop
full
antivir
activ
even
wash
exposur
antiinterferon
antiserum
also
report
cell
expos
high
concentr
interferon
unitsml
develop
antivir
activ
much
rapidli
expos
low
level
unitsml
interferon
report
although
conflict
earlier
report
lockart
horn
baron
et
al
dianzani
et
al
shed
light
implic
interferon
involv
pathogenisi
declercq
suggest
antitumor
effect
interferon
induc
poli
ri
poli
rc
discount
mice
base
reason
fact
administr
mice
amount
exogen
interferon
level
equal
found
blood
mice
inject
poli
ri
poli
rc
fail
duplic
antitumor
effect
poli
ri
poli
rc
inject
interpret
unfortun
tend
confus
evalu
interferon
antitumor
agent
assum
circul
interferon
repres
total
product
level
disregard
fact
point
local
produc
interferon
induc
significantli
higher
antivir
state
surround
cell
induc
circul
interferon
emphas
evalu
kinet
data
develop
interferoninduc
antivir
effect
metabol
process
may
occur
lag
period
viru
replic
sever
hour
metabol
process
may
requir
develop
antivir
state
true
assess
involv
metabol
event
establish
antivir
state
time
achiev
specif
block
inhibit
event
avail
metabol
requir
develop
viru
resist
interferon
antivir
substanc
induc
cell
produc
antivir
substanc
infer
observ
dnadepend
rna
transcript
actinomycin
inhibit
de
novo
protein
synthesi
puromycin
inhibit
requir
cell
becom
resist
virus
lockart
taylor
friedman
sonnabend
number
rnatranscript
protein
synthesi
inhibitor
shown
variou
investig
block
develop
antivir
state
interferontr
cell
nichol
tershak
pfluorophenylalanin
friedman
sonnabend
sonnabend
friedman
cycloheximid
stewart
ii
et
al
use
actinomycin
dianzani
et
al
conclud
messeng
rna
code
antivir
protein
synthes
within
hr
initi
interferoncel
contact
enucl
cell
demonstr
two
group
incap
develop
antivir
activ
radk
et
al
young
et
al
result
clearli
show
cellular
rna
protein
synthesi
requir
cell
develop
viru
resist
exposur
interferon
investig
assum
data
demonstr
interferon
induc
transcript
cellular
mrna
code
antivir
protein
precursor
subsequ
translat
mrna
give
rise
develop
antivir
state
model
rather
simplist
date
testabl
mrna
code
antivir
protein
isol
though
one
recent
suggest
ershov
et
al
ershov
et
al
antivir
protein
identifi
altern
model
put
forward
account
depend
antivir
state
develop
de
novo
rna
protein
synthesi
one
model
propos
interferon
may
involv
antivir
machineri
de
novo
synthesi
rna
protein
serv
product
permeas
transport
interferon
exterior
bind
site
within
cell
sheaf
stewart
b
c
stewart
sheaff
sinc
interferonproduc
cell
becom
resist
viru
exposur
interferon
without
vengri
et
al
interferon
induct
permeas
must
therefor
induc
exterior
cell
surfac
model
seem
like
stabil
antivir
state
cell
capabl
sustain
antivir
state
extend
period
time
provid
interferon
level
remain
stabl
extracellular
environ
remov
extracellular
interferon
caus
decay
antivir
state
rate
decay
antivir
state
depend
number
factor
metabol
state
popul
concentr
interferon
use
induct
antivir
state
isaac
westwood
report
chick
cell
sustain
antivir
state
sever
day
incub
serumfre
maintan
medium
rapidli
lost
viral
resist
incub
growth
medium
paucker
cantel
found
complet
decay
viral
resist
l
cell
sever
cell
gener
follow
remov
interferon
medium
friedman
sonnabend
observ
partial
loss
antivir
activ
chick
embryo
cell
incub
interferonfre
medium
hr
import
realiz
bound
interferon
elut
cell
thu
low
level
elut
interferon
fresh
cultur
medium
may
delay
decay
antivir
state
interferonfre
medium
true
decay
rate
antivir
state
may
arriv
incorpor
antibodi
interferon
fresh
medium
variat
decay
rate
cultur
may
due
differ
interferon
concentr
use
induc
antivir
state
suggest
either
variat
magnitud
antivir
state
level
releas
elut
interferon
wash
cultur
variat
exist
even
experi
report
investig
albeit
year
later
baron
et
al
report
interferontr
mous
embryo
cell
lost
viru
resist
gradual
hr
period
later
dianzani
et
al
report
viral
resist
remain
maxim
level
hr
remov
interferon
rapidli
decay
undetect
level
next
hr
baron
et
al
found
addit
actinomycin
cycloheximid
fluorophenylalanin
medium
remov
interferon
result
increas
decay
rate
antivir
state
sinc
sever
investig
report
contradict
result
chani
et
al
report
potenti
antivir
state
actinomycin
treatment
l
cell
lab
koehren
obtain
similar
result
chick
cell
radk
et
al
found
enucl
chick
cell
sustain
viru
resist
significantli
longer
normal
chick
cell
lab
koehren
report
antivir
state
decay
rapidli
remov
interferon
chick
cell
cultur
complet
disappear
within
hr
addit
cycloheximid
hr
remov
interferon
partial
fulli
restor
antivir
state
depend
time
addit
inhibitor
author
suggest
cycloheximid
act
block
synthesi
postul
regulatori
protein
revers
inactiv
antivir
protein
express
possibl
induct
viru
resist
interferon
like
induct
interferon
posttranscript
control
similarli
superinduc
anoth
factor
contribut
appar
variat
decay
rate
antivir
state
type
viru
use
viru
essenti
compon
replic
rapid
turnov
rate
would
abl
restor
product
viru
compon
destroy
antivir
state
thu
fals
indic
prolong
antivir
state
howev
virus
stabl
essenti
replic
compon
would
capabl
viru
product
antivir
state
fade
marcu
sekellick
viral
resist
induc
cell
interferon
capabl
inhibit
virus
everi
known
type
contrast
specif
antibodi
viru
use
product
howev
differ
degre
inhibit
differ
virus
gener
data
led
investig
infer
virus
interferon
sensit
other
interferon
resist
grossberg
rather
cell
speci
spectrum
viru
inhibit
develop
treat
interferon
author
attempt
compar
interferon
sensit
differ
virus
use
data
collect
differ
viru
assay
method
eg
singlecycl
viru
yield
reduct
multiplecycl
viru
yield
reduct
plaqu
reduct
cytopathiceffect
inhibit
rodger
et
al
hilfenhau
et
al
adam
et
al
dubuy
et
al
harri
et
al
comparison
meaningless
stewart
ii
sulkin
viru
resist
establish
interferontr
cell
characterist
cell
type
depend
type
interferon
use
stewart
ii
lockart
first
demonstr
monkey
interferon
induc
human
cell
viru
resist
spectrum
human
cell
investig
also
found
cell
speciesrel
viru
resist
phenomenon
ahl
rump
ito
montagni
evid
interferonact
mechan
determin
treat
cell
origin
interferon
speci
provid
observ
human
interferon
induc
mousetyp
phosphoryl
protein
humanmous
hybrid
cell
contain
human
chromosom
propos
code
interferon
receptor
complet
mous
genet
materi
hallum
et
al
suggest
differenti
decay
rate
antivir
state
virus
might
produc
artifactu
differ
viru
resist
assay
method
use
plaqu
reduct
investig
use
mention
techniqu
viru
assay
simultan
obtain
similar
spectra
resist
differ
virus
regardless
viru
assay
method
stewart
ii
lockart
khoobyarian
ito
montagni
rel
virussensit
spectra
interferoninduc
resist
list
tabl
ho
ender
glasgow
et
al
smorodintsev
et
al
stewart
li
desmyt
unpublish
data
plaquereduct
assay
sindbi
vsv
rubella
rhino
sfv
vaccinia
adeno
adeno
adeno
armstrong
merigan
came
et
al
desmyt
et
al
gauagher
khoobyarian
stewart
ii
et
al
singlecycl
yield
reduct
marchenko
et
al
murphi
et
al
oie
et
al
stewart
ii
lockart
b
chicken
interferon
chicken
cell
cytopathiceffect
inhibit
assay
wee
eee
vaccinia
fowl
plagu
ndv
pseudorabi
herp
simplex
vilcek
vilcek
rada
plaquereduct
assay
onyongnyong
chikungunya
vaccinia
japanes
enceph
sfv
vsv
fowl
plagu
ndv
friedman
gifford
et
al
grossberg
scherer
hallum
et
al
portnoy
merigan
ruizgomez
isaac
yieldreduct
assay
sendai
melinfluenza
fowl
plagu
burk
isaac
c
mous
interferon
mous
cell
plaquereduct
assay
vaccinia
sindbi
emc
eee
herp
simplex
vsv
sfv
glasgow
habel
stewart
ii
et
al
virus
list
decreas
order
sensit
interferon
abbrevi
eee
eastern
equin
enceph
cmv
cytomegaloviru
emc
encephalomyocard
ndv
newcastl
diseas
viru
sfv
semliki
forest
viru
vsv
vesicular
stomat
viru
rel
sensit
virus
resist
induc
interferon
also
use
character
differ
molecular
speci
interferon
vilcek
et
al
found
human
leukocyt
human
fibroblast
interferon
induc
similar
spectra
viru
resist
molecular
speci
human
leukocyt
interferon
isol
sdspolyacrylamid
gel
induc
order
rel
viru
resist
sizespeci
mous
interferon
isol
sdspolyacrylamid
gel
stewart
ii
unpublish
data
past
decad
variou
model
propos
describ
mechan
action
interferon
colbi
morgan
kleinschmidt
sonnabend
friedman
metz
b
friedman
joklik
lewi
et
al
progress
slow
propos
new
model
rash
experi
attempt
either
substanti
disprov
particular
model
vogu
quit
possibl
contradict
publish
data
partli
due
crude
prepar
interferon
use
advanc
interferon
purif
techniqu
recent
studi
perform
interferon
prepar
high
specif
activ
volumin
inform
abil
interferon
inhibit
virusspecif
protein
synthesi
joklik
merigan
salb
carter
levi
b
levi
carter
kerr
et
al
kerr
esteban
metz
metz
esteban
friedman
friedman
et
al
indic
clearli
least
one
mechan
interferon
action
translat
level
action
interferon
transcript
level
also
report
inhibit
viral
mrna
synthesi
polymerasecontain
virus
marcu
et
al
oxman
levin
biali
colbi
mander
et
al
perhap
inhibit
viral
polymeras
function
report
claim
inhibitori
action
interferon
step
viru
infect
multipl
subsequ
initi
state
viru
attach
penetr
uncoat
viral
mrna
protein
synthesi
matur
final
releas
matur
virus
billiau
one
school
thought
maintain
effect
mere
multipl
express
singl
interferon
action
mechan
name
translat
inhibit
other
suggest
multipl
mechan
interferon
action
stewart
ii
lockart
hallum
et
al
stewart
ii
et
al
marcu
et
al
friedman
evid
interferon
action
event
viral
replic
discuss
follow
section
earli
experi
virus
shown
viru
adsorpt
unaffect
treat
cell
interferon
ho
ender
wagner
cantel
paucker
stewart
ii
sulkin
morgan
et
al
gener
viral
adsorpt
unaffect
howev
mani
facet
interferon
action
variou
virus
report
alter
cell
membran
interferon
treatment
dictat
closer
look
influenc
interferon
viru
adsorpt
gener
statement
substanti
wide
believ
interferon
inhibit
uncoat
viru
stem
indirect
data
limit
direct
data
indirect
evid
base
fact
interferon
inhibit
viru
replic
cell
infect
either
intact
virion
infecti
rna
extract
certain
virus
ho
ho
desom
et
al
mayer
et
al
mayer
et
al
grossberg
holland
stewart
ii
et
al
data
thu
supposedli
prove
interferon
action
must
step
beyond
uncoat
viru
sonnabend
friedman
friedman
howev
interferon
effect
may
one
step
direct
studi
show
lack
effect
interferon
viru
uncoat
report
reoviru
wieb
joklik
galster
lengyel
recent
data
suggest
certain
viru
infect
viru
uncoat
may
affect
interferon
treatment
yamato
report
viru
infect
initi
infecti
viral
dna
slightli
sensit
interferon
treatment
wherea
infect
initi
intact
virion
quit
sensit
interferon
inhibit
demonstr
repeatedli
oxman
colleagu
oxman
black
oxman
levin
oxman
et
al
oxman
et
al
b
metz
et
al
metz
et
al
stewart
ii
l
lm
investig
yakobson
et
al
b
spectrum
interferon
action
differ
step
replic
differ
virus
may
plausibl
explan
first
evid
interferon
action
inhibit
primari
transcript
report
marcu
et
al
vesicular
stomat
viru
infect
chick
cell
similar
effect
later
seemingli
confirm
human
cell
mander
et
al
subsequ
monkey
cell
marcu
sekellick
investig
found
signific
discrep
interferon
sensit
earli
vsv
transcript
product
result
secondari
transcript
baxt
et
al
suggest
appar
primari
transcript
effect
interferon
due
trivial
effect
similarli
wieb
joklik
found
reoviru
yield
inhibit
significantli
interferon
primari
reoviru
transcript
slightli
depress
repik
et
al
also
discount
differ
primari
inhibit
influenza
viral
rna
transcript
interferonand
noninterferontr
cell
conclud
inhibit
transcript
biali
colbi
report
transcript
inhibit
vaccinia
virusinfect
chick
cell
treat
interferon
could
possibl
due
effect
cycloheximid
interferon
treatment
fact
analysi
poxviru
infect
interferontr
cell
reveal
earli
rna
vaccinia
viru
synthes
rather
inhibit
level
rna
synthes
enhanc
level
interferontr
cell
joklik
merigan
jungwirth
et
al
b
osterhoff
et
al
esteban
metz
horak
et
al
metz
et
al
metz
esteban
metz
clear
explan
discrep
convinc
evid
primari
inhibit
transcript
interferon
treatment
come
viru
studi
oxman
colleagu
demonstr
earli
rna
synthesi
monkey
cell
markedli
inhibit
oxman
levin
wherea
viru
adsorpt
penetr
uncoat
affect
metz
et
al
contradict
yamamoto
et
al
show
uncoat
inhibit
may
respons
appar
transcriptioninhibitori
activ
interferon
treatment
metz
et
al
suggest
inhibit
rna
transcript
could
due
either
reduc
level
transcript
viral
genom
elev
level
degrad
viral
rna
within
nucleu
howev
report
revers
blockag
viral
rna
releas
nucleu
kci
suggest
physiolog
blockag
rather
true
reflect
action
interferon
treatment
marcu
et
al
report
membranebound
ribonucleas
chick
cell
treat
interferon
suggest
nucleas
activ
could
mechan
interferon
action
howev
nucleas
activ
could
found
hamster
monkey
cell
present
chick
cell
treat
interferon
maenner
brandner
date
clearcut
evid
inhibitori
action
interferon
viral
rna
transcript
appear
though
low
inhibit
report
variou
cellviru
system
suffici
account
inhibit
viru
replic
consider
data
gather
inhibitori
action
interferon
translat
level
two
approach
studi
messag
function
input
viral
rna
interferontr
cell
b
studi
messeng
rna
translat
cellfre
protein
synthes
system
prepar
interferontr
cell
use
either
approach
possibl
show
translat
viral
messag
inhibit
interferon
treatment
prove
inhibitori
interferon
action
stage
viru
replic
show
interferon
treatment
inhibit
earli
viral
messag
translat
agre
signific
action
mechan
inhibit
viru
replic
sever
earli
studi
shown
earli
viral
rna
synthesi
inhibit
interferontr
cell
lockart
et
al
desom
et
al
taylor
friedman
sonnabend
gordon
et
al
mec
et
al
particular
viru
class
rna
suscept
interferoninduc
inhibit
other
case
viral
rna
replic
depend
synthesi
viral
rna
polymeras
thu
inhibit
viral
rna
synthesi
could
result
primari
inhibit
viral
rna
polymeras
synthesi
friedman
sreevalsan
similar
depress
viral
polymeras
synthesi
found
semliki
forest
viru
infect
chick
cell
sonnabend
et
al
mengoviru
infect
l
cell
miner
et
al
specul
mechan
interferon
action
base
find
includ
levi
carter
claim
case
mengoviru
inhibit
result
inabl
viral
ribosom
associ
viral
mrna
form
function
translat
unit
wherea
friedman
sreevalsan
found
inhibit
polysom
format
case
reoviru
infect
strong
inhibit
viral
protein
synthesi
observ
minim
level
inhibit
viral
rna
transcript
wieb
joklik
studi
vaccinia
viru
infect
indic
thymidin
kinas
induct
vaccinia
viru
inhibit
interferon
treatment
chick
cell
bodo
jungwirth
ghosh
gifford
levin
et
al
ohno
nozima
mous
cell
barban
baron
suggest
mage
et
al
celldirect
primari
uncoat
vaccinia
viru
proce
normal
viraldirect
secondari
uncoat
viru
inhibit
interferon
viru
remain
core
particl
even
though
vaccinia
viral
mrna
form
interferontr
cell
polyadenyl
klesel
et
al
unabl
form
stabl
polysom
bodo
et
al
joklik
merigan
metz
esteban
metz
et
al
howev
one
nonantivir
effect
interferon
doublestrand
rnatoxicityenhanc
stewart
ii
et
al
complic
result
obtain
vaccinia
viru
studi
vaccinia
viru
infect
interferontr
cell
destroy
rapidli
control
untreat
cell
joklik
merigan
horak
et
al
stewart
ii
et
al
like
due
doublestrand
rna
synthes
vaccinia
virusinfect
cell
colbi
duesberg
thu
rapid
inhibit
cellular
viral
protein
synthesi
interferontr
cell
could
due
polysom
breakdown
andor
total
cell
destruct
anoth
viru
studi
extens
respect
interferon
action
suggest
inhibit
antigen
synthesi
interferontr
cell
oxman
black
may
due
either
uncoat
inhibit
yamamoto
et
al
transcript
inhibit
oxman
levin
find
graessmann
et
al
show
crna
microinject
interferontr
cell
also
inhibit
translat
strongli
suggest
primari
inhibitori
action
interferon
mechan
translat
level
recent
yakobson
et
al
demonstr
interferon
abl
fulli
induc
antivir
state
monkey
cell
preinfect
activ
synthes
antigen
addit
interferon
earli
late
protein
synthesi
complet
arrest
even
though
viral
mrna
synthesi
continu
unalt
rate
yakobson
et
al
infect
host
cellular
protein
synthesi
continu
unchang
thu
easier
draw
conclus
interferon
treatment
inhibit
viral
mrna
translat
system
vaccinia
viru
system
total
cell
destruct
take
place
rather
differ
approach
explain
action
interferoninduc
select
inhibit
viral
mrna
translat
taken
levi
riley
riley
levi
propos
interferontr
cell
abl
differenti
cellular
viral
messag
synthes
modifi
mrna
larger
normal
interferontr
cell
capabl
make
enzym
requir
effect
modif
cellular
mrna
puzzl
data
await
confirm
inhibit
viral
mrna
translat
cellfre
system
studi
interferon
actionmechan
cellfre
system
start
decad
ago
earli
studi
howev
perform
prior
refin
techniqu
cellfre
translat
system
although
interest
arous
pioneer
experi
best
consid
imagin
salb
propos
interferon
induc
translat
inhibitori
protein
combin
ribosom
inhibit
abil
bind
translat
viral
mrna
cellular
mrna
treatment
inhibit
ribosom
trypsin
restor
abil
translat
viral
mrna
levi
b
support
idea
claim
ribosom
interferontr
l
cell
bind
mengoviru
mrna
report
translat
polyuridyl
acid
tobacco
mosaic
viru
rna
inhibit
interferontr
cell
system
laboratori
unabl
substanti
differ
bind
viral
mrna
ribosom
control
interferontr
cell
kerr
et
al
select
translat
differ
mrna
friedman
howev
advent
mani
refin
techniqu
cellfre
protein
synthesi
enabl
investig
realist
studi
effect
interferon
treatment
viral
rna
translat
infectionactiv
antivir
action
friedman
et
al
found
viral
mrna
translat
cellfre
extract
prepar
normal
interferontr
cell
howev
extract
prepar
vaccinia
emc
virusinfect
interferontr
cell
would
translat
viral
messag
although
polyuridyl
acid
translat
uninhibit
kerr
et
al
kerr
et
al
conclud
interferoninduc
antivir
action
requir
viru
infect
activ
translat
inhibit
investig
studi
differ
system
report
viru
infect
necessari
inhibit
translat
viral
messag
interferontr
cell
polyuridyl
acid
howev
translat
inhibit
unidentifi
factor
inhibit
viral
mrna
propos
resid
ribosom
factor
could
remov
saltwash
ribosom
falcoff
et
al
falcoff
et
al
gupta
et
al
gupta
et
al
samuel
joklik
samuel
mayr
et
al
hiller
et
al
zilberstein
et
al
howev
disagr
among
investig
specif
translat
inhibit
falcoff
et
ai
gupta
et
al
gupta
et
al
hiller
et
al
report
nonspecif
inhibit
viral
cellular
hemoglobin
mrna
translat
interferontr
cell
extract
wherea
samuel
joklik
report
translat
system
capabl
discern
viral
mrna
cellular
mrna
inhibit
latter
unidentifi
factor
found
dalton
protein
isol
saltwash
interferontr
ribosom
factor
abl
inhibit
translat
viral
mrna
ad
normal
cell
extract
translationinhibit
protein
exhibit
speci
specif
observ
interferon
host
cell
activ
whether
ad
homolog
heterolog
cell
extract
samuel
farri
also
possess
nucleolyt
activ
eppstein
samuel
lack
hostrang
specif
similar
transfer
viru
resist
interferontr
cell
nontreat
cell
close
contact
blalock
baron
ii
antivir
action
activ
doublestrand
rna
least
three
antivir
action
activ
doublestrand
rna
dsrna
phosphoryl
protein
activ
endonucleas
appear
low
molecular
weight
inhibitor
protein
synthesi
kerr
cowork
kerr
et
al
kerr
et
al
report
viral
infectiondepend
interferoninduc
inhibit
translat
cell
extract
inhibitori
activ
also
observ
dsrna
atp
ad
system
period
incub
cell
extract
dsrna
atp
could
remov
without
loss
translationinhibitori
action
suggest
synthesi
translationinhibitori
factor
appar
via
phosphoryl
exist
protein
robert
et
al
rnaor
dnacontain
viru
replic
dsrna
form
colbi
duesberg
thu
plausibl
inhibitori
action
depend
viru
infect
due
presenc
dsrna
studi
particular
translationinhibit
cellfre
system
contain
reaction
mixtur
dsrna
atp
interferontr
cell
extract
mani
investig
reveal
number
event
upon
addit
dsrna
although
minor
differ
exist
report
eg
slight
differ
molecular
weight
determin
surpris
note
degre
agreement
lebleu
et
al
sen
et
al
zilberstein
et
al
b
robert
et
al
revel
et
al
galster
lengyel
kerr
et
al
ratner
et
al
yakobson
et
al
b
revel
lieberman
et
al
swetli
ostertag
shaila
et
al
rossi
et
ai
b
c
summari
report
show
two
major
protein
phosphoryl
reaction
mixtur
molecular
weight
larger
one
rang
dalton
smaller
one
dalton
propos
initi
factor
ribosom
translat
complex
revel
endonucleas
activ
observ
degrad
cellular
viral
mrna
studi
reoviru
mrna
found
endonucleas
degrad
larger
mrna
faster
smaller
mrna
dsrna
isol
reoviru
subparticl
interferontr
cell
contain
shorter
dsrna
suggest
interferoninduc
endonucleasegener
degrad
endonucleas
activ
appar
limit
one
cell
type
sinc
found
mani
speci
low
molecular
weight
inhibitor
translat
lmwit
found
extract
interferontr
cell
dsrna
atp
ad
robert
et
al
lmwit
identifi
unusu
oligonucleotid
follow
structur
formula
pppazpyazpya
kerr
brown
ball
white
lmwit
appear
inhibitor
lag
period
min
addit
translat
system
rabbit
reticulocyt
termin
translat
seem
like
induc
regul
format
inhibitor
hovanessian
et
al
kerr
et
al
report
lmwit
synthes
enzym
present
interferontr
cell
extract
inhibitor
found
sensit
alkali
alkalin
phosphatas
snake
venom
phosphodiesteras
resist
variou
nucleas
micrococc
lmwit
activ
compound
capabl
inhibit
translat
nanomolar
concentr
appar
action
lmwit
report
activ
endonucleas
clemen
william
interest
see
inhibitor
exert
select
translat
inhibit
viral
rna
intact
cell
whether
enhanc
toxic
dsrna
intact
cell
appar
interferon
treatment
mani
type
cell
induc
enzym
presenc
dsrna
atp
phosphoryl
protein
lmwlt
werenn
rosseau
phosphoryl
phenomenon
also
found
cell
treat
type
ii
interferon
wietzerbin
et
al
dsrnaand
atptreat
extract
virusresist
mous
cell
appar
spontan
produc
low
level
mous
interferon
jarvi
colbi
treat
cell
extract
humanmous
hybrid
contain
chromosom
human
origin
dsrna
atp
slate
et
al
found
mous
dalton
protein
marker
phosphoryl
human
protein
marker
similarli
obtain
human
cell
extract
report
slightli
larger
compound
appar
ident
lmwit
synthes
enzym
rabbit
reticulocyt
hovanessian
kerr
also
found
cooper
farrel
cytoplasm
extract
interferontr
l
cell
mix
dsrna
atp
inhibit
protein
synthesi
rabbit
reticulocyt
system
inhibit
appar
due
phosphoryl
mettrna
bind
factor
result
defect
peptid
chain
initi
addit
initi
factor
reduc
inhibit
translat
suggest
interferon
may
inhibit
translat
via
phosphoryl
action
interferon
treatment
translat
inhibit
investig
addit
compon
essenti
protein
synthesi
cellfre
extract
observ
relief
translationinhibit
transfer
rna
obviou
compon
investig
detail
addit
trna
found
allevi
translationinhibit
interferontr
cell
extract
mani
investig
gupta
et
al
gupta
et
al
content
et
al
content
et
al
hiller
et
al
weissenbach
et
al
zilberstein
et
al
mayr
et
al
revers
effect
could
detect
differ
trna
viral
cellular
mrna
report
trna
leu
respons
revers
translat
inhibit
polyuridyl
acid
wherea
mengo
mrna
trna
teu
partial
revers
inhibit
polycytidyl
acid
found
translationinhibit
interferon
surprisingli
translat
better
interferoncel
extract
normal
cell
extract
interest
puzzl
observ
sever
investig
suggest
perhap
trna
interferontr
cell
extract
labil
colbi
et
al
found
trna
control
interferontr
mous
l
cell
number
trna
le
isoacceptor
trna
revers
translationinhibit
reoviru
mrna
equal
content
et
al
made
similar
observ
thu
negat
suggest
differ
trna
labil
paramet
translationinhibit
found
inhibit
interferontr
cell
extract
methyl
reoviru
mrna
sen
et
al
shaila
et
al
identif
inhibitor
discharg
amino
acid
previous
esterifi
viral
mrna
sela
et
al
signific
either
describ
effect
respect
mechan
interferon
action
still
remain
elucid
evid
studi
rnatumor
virus
shift
attent
mechan
action
interferon
earli
stage
viru
infect
describ
later
stage
viru
replicationnmatur
releas
billiau
et
al
friedman
ramseur
friedman
et
al
investig
two
laboratori
observ
accumul
rnatumor
viru
compon
interferontr
cell
also
releas
significantli
less
ctype
particl
normal
cell
late
arrest
viru
replic
appar
mechan
action
interferon
tumor
virus
replic
inhibit
mechan
rnaand
dnatumor
virus
interferon
report
bader
birg
meyer
fitzgerald
gottliebstematski
et
al
oxman
et
al
peri
et
al
van
griensven
et
al
tumor
viru
replic
viral
genom
duplic
incorpor
cell
genom
state
cell
becom
chronic
proviru
carrier
capabl
produc
viru
either
spontan
induc
treatment
cultur
interferon
retain
cultur
medium
prior
infect
murin
sarcoma
viru
prevent
transform
cultur
viru
product
howev
interferon
treatment
infect
effect
suggest
inhibit
viru
product
synthesi
incorpor
provir
rna
fitzgerald
peri
et
al
pitha
et
al
sarma
et
al
cultur
infect
oncornavirus
produc
virus
induc
treat
cultur
pyrimidin
cycloheximid
glucocorticoid
treatment
induc
cultur
interferon
decreas
amount
viru
releas
blaineau
et
al
lieberman
et
al
pitha
et
al
ramoni
et
al
ramseur
friedman
rossi
et
al
b
c
swetli
ostertag
wu
et
al
wu
et
al
amount
intracellular
gsantigen
produc
cultur
induc
iododeoxyuridin
affect
interferon
treatment
murin
leukemia
viru
follow
observ
report
interferon
treatment
upon
remov
interferon
viru
product
rapidli
resum
b
viral
protein
revers
transcriptas
unchang
friedman
ramseur
friedman
et
al
pitha
et
al
shapiro
et
al
c
cleavag
inhibit
sever
precursor
major
viral
protein
shapiro
et
al
number
viru
particl
bud
surfac
cell
greatli
increas
extracellular
viru
decreas
chang
et
al
e
bud
particl
disproportion
high
transcriptasetoinfect
ratio
pitha
et
al
case
ctype
particl
found
upon
interferon
treatment
cultur
chronic
produc
particl
number
particl
associ
cultur
reduc
increas
wherea
extracellular
viru
markedli
depress
allen
et
al
billiau
billiau
et
al
billiau
et
al
billiau
et
al
billiau
et
al
chang
et
al
friedman
friedman
ramseur
friedman
et
al
oshaughnessi
et
al
peri
et
al
ramseur
friedman
salzberg
et
ai
shapiro
et
al
van
griensven
et
al
suggest
van
griensven
ctype
particl
defect
rna
content
biuiau
howev
unabl
detect
physic
defici
case
moloney
leukemia
viru
interferon
treatment
infect
cell
caus
product
virion
high
particleinfect
ratio
accumul
larg
dalton
glycoprotein
suspect
uncleav
precursor
viral
protein
chang
et
al
wong
et
al
thu
appear
inhibitori
action
interferon
tumor
viru
replic
later
stage
replic
either
assembl
matur
releas
effect
could
achiev
inhibit
cleavag
viral
compon
inhibit
translat
viral
genom
alter
cell
membran
thicken
mucopolysaccharid
layer
interferontr
cell
propos
billiau
et
al
even
case
incomplet
inhibit
viru
replic
partial
reduct
synthesi
viral
compon
may
lead
increas
yield
defect
viru
particl
case
interferon
would
success
limit
subsequ
viru
cycl
viru
infect
cell
subsequ
product
progeni
virus
involv
mani
stage
could
subject
inhibitori
action
interferon
although
bulk
inform
avail
interferon
mechan
action
seem
point
translat
inhibit
briefli
review
viru
infect
process
propos
simpl
model
possibl
inhibitori
action
interferon
infect
process
attach
penetr
pinocytosi
uncoat
viru
cell
normal
seem
inhibit
interferon
treatment
cell
uncoat
infect
process
depend
upon
type
genet
materi
carri
viru
eg
singlestrand
rna
dna
posit
neg
strand
doublestrand
rna
dna
negativestrand
rna
viru
progeni
viral
protein
directli
translat
templat
howev
viru
contain
either
positivestrand
rna
dna
singl
doubl
least
one
round
transcript
requir
progeni
viral
protein
translat
extra
step
replic
process
subject
interferon
inhibit
follow
way
templat
degrad
transcriptas
inactiv
initi
transcript
arrest
elong
transcript
inhibit
final
error
transcript
process
inhibit
polyadenyl
cap
transcript
splice
error
transcript
could
also
occur
infect
viru
except
minusstrand
rna
virus
surviv
inhibitori
action
readi
translat
progeni
viral
protein
multifacet
inhibit
translat
interferon
could
occur
follow
templat
degrad
bind
mrna
ribosom
inhibit
initi
translat
inhibit
either
via
defici
initi
factor
inactiv
initi
factor
elong
arrest
either
alter
defici
elong
factor
andor
transfer
rna
final
defect
termin
either
prematur
releas
inhibit
releas
accumul
doublestrand
rna
replic
form
could
signal
initi
success
viru
infect
event
presenc
dsrna
structur
within
cell
could
trigger
secondlin
mechan
induc
interferon
within
cell
tri
harder
inhibit
viral
replic
process
mechan
involv
expenditur
atp
activ
kinas
anoth
enzym
synthes
low
molecular
weight
inhibitor
translat
lmwit
inactiv
initi
factor
activ
endonucleas
endonucleas
inhibit
translat
degrad
viral
cellular
mrna
accumul
dsrna
cell
interferoninduc
firstand
secondlin
defens
fail
could
caus
cell
undergo
suicid
via
toxic
enhanc
dsrna
interferon
treatment
thu
prevent
viru
multipl
viral
infect
progress
beyond
translat
inhibit
replic
process
could
still
inhibit
prevent
cleavag
translat
precursor
protein
final
interferoninduc
membran
alter
may
inhibit
releas
matur
viru
interferon
treatment
may
also
caus
increas
assembl
defect
virion
releas
interfer
subsequ
cycl
viru
infect
replic
seem
interferon
treatment
trigger
myriad
action
host
cell
way
arm
treat
cell
mani
altern
mean
defens
mani
type
viru
infect
replic
process
els
fail
cell
set
self
destruct
lysi
toxic
enhanc
dsrna
prevent
viru
replic
therebi
alter
pathogenesi
viru
infect
term
nonantivir
activ
nava
interferon
coin
stewart
ii
et
al
prior
report
describ
activ
interferon
antivir
mostli
disregard
due
impur
found
interferon
prepar
mediat
antivir
activ
interferon
improv
purif
techniqu
certain
interferon
caus
number
alter
cell
list
nava
grow
steadili
nava
obvious
relat
may
prove
caus
interferon
examin
nava
follow
section
emphasi
determin
whether
actual
induc
interferon
contamin
literatur
publish
aspect
interferonolog
tremend
henc
repres
refer
cite
interferon
shown
inhibit
sever
microbi
agent
chlamydia
sp
sueltenfuss
pollard
hanna
et
al
hanna
et
al
protozoa
includ
plasmodium
sp
suntharasamai
rytel
jahiel
et
al
merigan
rickettsia
sp
kazar
et
al
even
bacteria
shigella
flexneri
gober
et
al
sensit
microb
interferon
found
gener
less
viru
vesicular
stomat
viru
mechanist
unrev
virus
exhibit
broad
spectrum
sensit
interferon
induc
also
report
inhibit
multipl
klebsiella
pneumonia
weinstein
et
ai
pasteurella
tularensi
diplococc
pneumonia
giron
et
al
mycobacterium
lepra
levi
merigan
enhanc
fungal
infect
worthington
hasenclev
trypansoma
cruzi
kumar
et
al
listeria
monocytogen
gruenewald
levin
sinc
interferon
exhibit
activ
observ
best
classifi
cursori
relationship
interferon
action
observ
involv
interferon
directli
rabbit
interferon
found
inhibitori
toxoplasma
gondii
rabbit
cell
schmuni
et
al
herman
demonstr
interferon
interfer
plasmodium
gallinaceum
malaria
chicken
herman
herman
et
al
prime
defin
increas
product
interferon
cell
treat
interferon
prior
exposur
induc
block
defin
decreas
product
interferon
cell
treat
high
concentr
interferon
prior
induct
two
phenomenon
differ
amount
interferon
use
pretreat
dramat
differ
end
result
compar
contrast
two
nonantivir
action
interferon
attempt
resolv
reason
diametr
result
repeat
exposur
induc
interferon
found
also
caus
prime
burk
isaac
ho
breinig
mahdi
ho
billiau
goorha
gifford
b
interferonprim
cell
produc
interferon
normal
cell
induc
poli
ri
poli
rc
rosztoczi
mec
stewart
ii
et
al
prime
cell
size
requir
poli
ri
poli
rc
molecul
trigger
interferon
product
stewart
ii
declercq
interferonblock
cell
also
block
interferon
product
induc
poli
ri
poli
rc
youngner
hallum
stewart
ii
et
al
golgher
paucker
rousset
barmak
vilcek
develop
prime
differ
develop
block
tempor
aspect
cell
becom
prime
less
hr
treat
unit
interferon
per
ml
giron
et
al
stewart
ii
et
al
wherea
sever
hour
exposur
unit
interferon
per
ml
requir
block
develop
paucker
boxaca
stewart
ii
et
al
barmak
vilcek
rousset
lobodzinska
et
al
protein
synthesi
host
cell
requir
develop
prime
sinc
cell
treat
interferon
presenc
cycloheximid
puromycin
pfluorophenylalanin
becam
fulli
prime
stewart
ii
et
al
knight
rosztoczi
barmak
vilcek
protein
synthesi
howev
requir
exposur
interferon
block
develop
protein
synthesi
arrest
cell
becom
block
even
prolong
exposur
high
concentr
interferon
instead
becom
prime
thu
time
period
exposur
requir
protein
synthesi
appear
major
distinct
prime
block
develop
develop
prime
block
subsequ
product
interferon
alter
level
enhanc
depress
occur
quickli
normal
cell
paucker
boxaca
stewart
ii
et
al
b
rosztoczi
mec
rosztoczi
stewart
ii
et
al
ustacelibi
william
friedman
levi
et
ai
stewart
ii
declercq
levykownig
et
al
product
interferon
interferontr
cultur
requir
rna
protein
synthesi
lag
period
requir
interferon
messeng
rna
synthesi
shorter
prime
cell
demonstr
actinomycin
treatment
find
suggest
interferon
mrna
synthesi
prime
cell
much
faster
probabl
shorten
induct
process
cell
cultur
normal
short
inductionlag
phase
observ
quicker
respons
time
cell
pretreat
interferon
stewart
ii
et
al
tovel
cantel
barmak
vilcek
data
suggest
interferon
prime
remov
restrict
induct
process
normal
cell
long
inductionlag
must
perform
initi
interferon
mrna
synthesi
stewart
ii
et
al
recent
experi
laboratori
directli
demonstr
interferon
mrna
made
quickli
prime
cell
normal
cell
increas
amount
interferon
mrna
prime
cell
compar
unprim
cell
halflif
interferon
mrna
prime
unprim
cell
thu
increas
interferon
yield
must
result
effici
translat
interferon
mrna
abreu
w
stewart
ii
unpublish
data
interferon
prime
also
remov
requir
mous
cell
deae
dextran
induc
poli
ri
poli
rc
rosztoczi
stewart
ii
et
al
suggest
cell
surfac
alter
interferon
treatment
prime
activ
human
cell
spite
claim
contrari
declercq
et
al
appar
determin
chromosom
frankfort
et
al
final
question
whether
prime
andor
block
activ
interferon
prepar
realli
due
interferon
copurifi
contamin
prime
activ
found
everi
speci
test
interferon
prepar
assay
prime
activ
exhibit
defin
hostrang
activ
antivir
activ
levykoenig
et
al
stewart
ii
et
al
ito
kobayashi
rousset
interferon
found
maintain
constant
ratio
antivir
unitprim
block
unit
purif
stewart
ii
et
al
purif
stewart
ii
recent
found
mous
interferon
purifi
unitsmg
protein
abl
prime
cell
ratioantivir
unit
crude
lip
unitsmg
protein
semicrud
partial
purifi
purifi
unitsmg
highli
purifi
unitsmg
prepar
low
molecular
weight
modifi
form
mous
interferon
interferoid
also
ident
respect
nativ
mous
interferon
stewart
ii
lin
wiranowskastewart
unpublish
data
prime
block
factor
fulfil
criterion
accept
interferon
abil
interferon
prepar
inhibit
normal
cell
replic
event
cell
multipl
first
report
paucker
et
al
sinc
observ
subject
mani
disagr
one
side
claim
inhibit
due
interferon
et
al
gresser
et
al
b
gresser
et
al
lindahlmagnusson
et
al
tovey
et
al
knight
hilfenhau
karg
adam
et
al
tan
gaffney
et
al
hilfenhau
et
al
lee
et
al
oshaughnessi
et
al
mcneill
gresser
kishida
et
al
kishida
et
al
ohwaki
kawad
other
either
fail
observ
ihhibit
observ
fluctuat
ratio
antivir
cellmultiplicationinhibitori
activ
interferon
prepar
thu
assign
activ
factor
prepar
interferon
cocito
et
al
baron
et
al
levi
merigan
baron
isaac
marcu
salb
kishida
et
ai
borecki
et
al
fuchsberg
et
al
matsuzawa
kawad
one
reason
controversi
regard
cellmultiplicationinhibitori
activ
interferon
due
differ
assay
use
demonstr
effect
condit
delin
lindahlmagnusson
et
al
help
allevi
problem
viz
demonstr
cellmultiplicationinhibit
cmi
cultur
must
initi
suffici
low
densiti
allow
sever
day
observ
control
cell
cultur
reach
satur
despit
disclaim
evid
avail
vastli
favor
interpret
interferon
inhibit
cell
multipl
interferon
prepar
regardless
sourc
induc
agent
degre
puriti
exhibit
constant
ratio
antivir
cmi
activ
ident
defin
hostrang
activ
gresser
et
al
b
stewart
ii
et
al
babiuk
rous
b
mous
cell
resist
antivir
action
interferon
gresser
et
al
b
unabl
bind
interferon
also
resist
cmi
action
interferon
prepar
gresser
et
al
b
lindahlmagnusson
et
al
gresser
et
al
human
cell
trisom
chromosom
sensit
antivir
activ
human
interferon
tan
et
al
bind
interferon
wiranowska
stewart
stewart
ii
also
sensit
cmi
action
interferon
prepar
tan
cuppl
tan
c
individu
speci
interferon
human
mous
sourc
isol
sdspolyacrylamid
gel
electrophoresi
ident
respect
antivir
cmi
activ
knight
highli
purifi
prepar
interferon
shown
induc
cmi
equal
well
crude
prepar
highli
purifi
interferon
test
includ
mous
interferon
specif
activ
unitsmg
protein
gresser
stewart
ii
et
al
human
fibroblast
interferon
x
unitsmg
knight
human
leukocyt
interferon
purifi
singl
spot
twodimension
gel
electrophoresi
lin
et
al
mous
interferoid
purifi
unitsrag
protein
stewart
ii
et
al
interferoninduc
cell
inhibit
revers
event
gresser
et
al
b
paucker
et
al
gaffney
et
al
oshaughnessi
et
al
upon
remov
interferon
cell
return
normal
growth
rate
biolog
system
differ
type
cell
respond
cmi
activ
interferon
differ
degre
multipl
mous
cell
inhibit
almost
complet
unitsml
interferon
show
inhibit
unitsml
gresser
et
al
b
human
lymphoblastoid
cell
line
show
vast
differ
respons
cmi
activ
interferon
daudi
cell
inhibit
one
unit
less
other
resist
sever
thousand
unit
hilfenhau
et
al
hilfenhau
karg
primari
cell
cultur
usual
less
sensit
establish
cell
line
lindahlmagnusson
et
al
knight
lee
et
al
strander
einhorn
report
sever
line
osteosarcoma
cell
inhibit
human
leukocyt
interferon
sensit
nontumorderiv
line
cellmultiplicationinhibitori
effect
interferon
due
toxic
interferon
ratio
viabl
cell
count
total
cell
count
remain
inhibit
interferontr
cell
often
plateau
lower
satur
densiti
normal
cell
gresser
et
al
b
knight
collyn
dhoogh
et
al
report
intermitot
time
follow
timelaps
photomicrographi
markedli
progress
increas
phase
rather
arrest
given
phase
sokawa
et
al
report
interferon
suppress
transit
cell
quiescent
grow
state
interferon
also
found
inhibit
growth
normal
tumor
cell
vivo
inhibit
tumor
cell
vivo
discuss
section
describ
activ
interferon
normal
cell
vivo
induc
interferon
interferon
inhibit
multipl
allogen
syngen
bone
marrow
cell
irradi
mice
cerottini
et
al
inocul
hamster
poli
ri
poli
rc
result
discoveri
hemopoet
cellcoloni
format
inhibitor
serum
anim
mcneill
colleagu
mcneill
fleme
fleme
et
al
mcneill
et
al
interferon
induc
poli
ri
poli
rc
newcastl
diseas
viru
statolon
report
inhibit
mitot
respons
liver
cell
partial
hepatectomi
jahiel
et
al
later
interferon
shown
effect
frayssinet
et
al
repeat
inject
unit
per
day
interferon
newborn
mice
affect
growth
develop
anim
gresser
bourali
howev
dosag
increas
unit
per
day
newborn
mice
die
extens
liver
damag
one
week
gresser
et
al
inject
halt
day
liver
damag
appear
revers
anim
recov
sever
appar
recov
anim
die
month
later
progress
glomerulonephr
rivier
et
al
inocul
newborn
mice
lymphocyt
choriomening
viru
found
follow
patholog
decreas
weight
gain
liver
necrosi
death
inocul
antiinterferon
antiserum
anim
viru
level
increas
diseas
manifest
inhibit
suggest
chronic
virusinduc
interferon
led
decreas
weight
gain
liver
diseas
eventu
death
bekesi
et
al
also
report
repeat
inject
high
dose
interferon
akr
mice
caus
earli
death
mark
sign
wast
organ
atrophi
small
spleen
athym
exact
mechin
suppress
cell
multipl
interferon
far
approach
present
sinc
antivir
mechan
interferon
inhibit
viral
mrna
translat
easi
assum
cellular
mrna
also
inhibit
translat
earli
report
interferon
exert
effect
cell
metabol
joklik
merigan
levi
merigan
merigan
et
al
wagner
cocito
et
al
sonnabend
friedman
sonnabend
howev
refin
sophist
molecular
biolog
techniqu
experiment
design
result
report
demonstr
clearli
interferon
alter
metabol
cell
johnson
et
al
report
mous
interferon
unitsml
inhibit
amino
acid
incorpor
l
cell
effect
heterolog
cell
falcoff
et
al
report
mous
interferon
unitsml
consist
inhibit
endogen
protein
synthesi
l
cell
per
cent
inhibit
parallel
kinet
viru
resist
broutyboy
et
al
report
mous
cell
sensit
interferon
show
signific
decreas
total
cellular
rna
protein
synthesi
treat
interferon
wherea
cell
resist
interferon
show
effect
oshaughnessi
et
al
report
delay
thymidin
uptak
interferontr
synchron
l
cell
fuse
kuwata
also
found
reduc
synthesi
dna
protein
interferontr
human
rsa
cell
synchron
rsa
cell
stop
dna
synthesi
interferon
ad
phase
show
effect
ad
boundari
phase
chemostat
cultur
system
anim
cell
develop
tovey
cowork
tovey
et
al
tovey
tovey
mous
interferon
maintain
system
final
concentr
unitsml
continu
addit
effect
mous
cell
cultur
steadi
state
investig
follow
result
report
rapid
inhibit
thymidin
incorpor
within
hr
interferon
addit
deoxyadenosin
deoxydglucos
inhibit
amino
acid
uridin
uptak
observ
interferontr
cell
slow
normal
growth
also
restrain
stimul
prolifer
lindahlmagnusson
et
al
show
interferon
prepar
inhibit
dna
synthesi
induc
mous
splenic
lymphocyt
phytohemagglutinin
allogen
lymphocyt
blomgren
et
al
report
human
leukocyt
interferon
unitsml
suppress
human
lymphocyt
prolif
stimul
phytohemagglutinin
concanavalin
ppd
mix
lymphocyt
reaction
interferon
also
abl
suppress
cell
vivo
pacheco
et
al
report
spleen
cell
mice
inocul
interferon
unit
hr
excis
incorpor
thymidin
even
stimul
lectin
phytohemagglutinin
concanavalin
lipopolysaccharid
cuppl
tan
note
cell
syndrom
patient
exhibit
inhibit
dna
synthesi
greater
degre
normal
cell
interferon
treatment
prior
antigen
mitogen
stimul
addit
decreas
dna
synthesi
interferon
treatment
specif
cellular
constitu
enzym
also
report
inhibit
includ
decreas
tyrosin
amino
transferas
product
rat
htc
cell
expos
dexamethason
beck
et
al
vassef
et
al
inhibit
product
dehydrogenas
rat
glial
cell
induc
hydrocortison
hemisuccin
illing
et
al
suppress
induct
glutamin
synthetas
chick
embryon
neural
retina
hydrocortison
matsuno
et
al
data
indic
gener
restraint
induc
cell
interferon
recent
report
interferon
stimul
releas
prostaglandin
e
yaron
et
al
karmazyn
et
al
inhibitor
prostaglandin
e
product
cortisol
indomethacin
prevent
inhibitori
effect
interferon
synovi
fibroblast
growth
suggest
restraint
interferon
impos
may
secondari
effect
sinc
prostaglandin
e
capabl
regul
cell
replic
often
shown
direct
correl
abil
polynucleotid
induc
interferon
toxic
niblack
mccreari
stewart
ii
declercq
fact
two
properti
dsrna
separ
although
claim
made
omalley
et
al
ts
et
al
poli
ri
poli
rc
concentr
low
induc
interferon
synthesi
normal
cell
capabl
stimul
product
interferon
prime
cell
rosztoczi
also
found
markedli
sensit
normal
cell
toxic
dsrna
poli
ri
poli
rc
lyse
within
hr
stewart
ii
et
al
enhanc
sensit
toxic
also
found
sever
natur
synthet
dsrna
correl
rel
abil
polynucleotid
induc
interferon
minimum
requir
polynucleotid
size
induct
effect
stewart
ii
et
al
stewart
ii
declercq
fact
toxic
enhanc
seen
singlestrand
rna
dna
tiloron
endotoxin
coam
cycloheximid
actinomycin
deaedextran
rattlesnak
venom
diphtheria
toxin
cholera
toxin
suggest
enhanc
process
specif
dsrna
toxic
enhanc
also
observ
prime
cell
infect
vaccinia
viru
system
studi
mani
investig
respect
observ
compil
follow
interferontr
l
cell
began
convert
ghost
hr
vaccinia
viru
infect
hr
practic
cell
lyse
viral
gene
product
must
synthes
cell
lysi
occur
treatment
prime
cell
cycloheximid
actinomycin
time
infect
prevent
cell
lysi
joklik
merigan
horak
et
al
jungwirth
et
al
b
bodo
et
al
stewart
ii
et
al
data
suggest
viral
gene
product
viru
respons
lysi
interferontr
cell
along
observ
dsrna
found
vacciniainfect
cell
colbi
duesberg
add
specul
toxic
enhanc
specif
dsrna
similar
cell
lysi
phenomena
observ
interferonprim
cell
infect
vesicular
stomat
viru
katz
et
al
prime
human
conjunctiv
cell
infect
influenza
viru
green
mowshowitz
repeat
exposur
cell
poli
ri
poli
rc
billiau
et
al
martelli
jullien
possibl
due
induc
interferon
prime
cell
enhanc
toxic
dsrna
amount
interferon
requir
induc
effect
similar
requir
induc
resist
viru
extent
cell
destruct
depend
amount
interferon
use
prime
cell
amount
dsrna
appli
stewart
ii
et
al
lackov
borecki
sever
hour
treatment
interferon
requir
cell
develop
toxic
enhanc
time
protein
synthesi
requir
stewart
ii
unpublish
data
indic
toxic
enhanc
differ
prime
cellular
metabol
activ
requir
phenomenon
occur
addit
dsrna
interferontr
cell
lead
cell
lysi
within
hr
addit
dsrna
damag
cell
visibl
time
lysi
complet
hr
prior
lysi
intern
destruct
within
cell
detect
cytochem
stain
loss
succin
dehydrogenas
indic
injuri
mitochondria
diffus
acid
phosphatas
activ
suggest
lysosom
damag
nuclear
swell
concomit
decreas
protein
synthesi
hereman
et
al
demonstr
electron
microscopi
mitochondri
nuclear
damag
cell
prior
lysi
cell
treat
interferon
report
sensit
toxic
varieti
compound
eg
deaedextran
protamin
sulfat
methyl
albumin
concanavalin
lee
roze
katz
et
al
stewart
ii
et
al
howev
increas
sensit
seem
involv
mechan
dsrna
least
increas
toxic
concanavalin
may
relat
increas
bind
lectin
interferontr
cell
huet
et
al
toxic
enhanc
interferon
like
play
role
vivo
well
cell
cultur
presenc
interferon
virusinfect
patient
could
preclud
use
dsrna
therapeut
stewart
ii
et
al
virusinfect
mice
found
suscept
dsrna
normal
uninfect
mice
inject
rabbit
human
leukocyt
interferon
million
unit
per
rabbit
newcastl
diseas
viru
combin
caus
death
rabbit
wherea
neither
viru
interferon
singli
lethal
cantel
et
al
follow
observ
intramuscularli
inocul
interferon
bind
local
harmon
jani
stewart
cowork
use
combin
inject
interferon
follow
poli
ri
poli
rc
palpat
autochthon
tumor
induc
moloney
sarcoma
viru
mice
declercq
stewart
ii
interferon
alon
ineffect
poli
ri
poli
rc
margin
effctiv
sequenti
inject
interferon
poli
ri
poli
rc
effect
regress
tumor
growth
prolong
life
encourag
preliminari
observ
definit
warrant
investig
toxicityenhanc
factor
interferon
prepar
shown
interferon
purifi
interferon
stewart
ii
et
al
one
millionfold
stewart
ii
et
al
increas
interferon
specif
activ
ident
ratio
antivir
toxicityenhanc
activ
mous
interferon
found
mous
interferon
purifi
unitsmg
protein
pure
mous
interferoid
stewart
ii
et
al
describ
nonantivir
activ
prime
block
cellmultiplicationinhibit
toxicityenhanc
clearli
ascrib
interferon
follow
nonantivir
activ
well
character
clearli
due
interferon
studi
use
pure
interferon
soon
clarifi
involv
activ
addit
prime
activ
interferon
interferon
product
appar
also
increas
abil
cell
produc
product
yaron
et
al
yaron
et
al
report
either
poli
ri
poli
rc
human
interferon
could
enhanc
product
hyaluron
acid
prostaglandin
e
human
rheumatoid
nonrheumatoid
synovi
fibroblast
product
hyaluron
acid
led
worker
suggest
relationship
interferon
product
pathogenesi
accumul
joint
fluid
viru
infect
sinc
prostaglandin
e
mediat
inflammatori
process
tempt
specul
interferon
fever
follow
inocul
human
fibroblast
interferon
fibril
respons
often
observ
system
administr
human
leukocyt
interferon
may
relat
activ
interferon
also
found
enhanc
amount
certain
induc
cell
product
pretreat
mous
interferon
unitsml
enhanc
amount
aryl
hydrocarbon
hydroxylas
produc
cultur
induc
benzanthracen
nebert
friedman
ida
et
al
found
either
viru
poli
ri
poli
rc
human
leukocyt
interferon
enhanc
abil
human
leukocyt
releas
histamin
expos
ragwe
antigen
e
antiig
suggest
interferon
may
play
role
precipit
potenti
attack
bronchial
asthma
viral
infect
skurkovich
eremkina
suggest
role
interferon
allergi
propos
use
antiinterferon
immunoglobulin
treatment
certain
autoimmun
diseas
interferon
treatment
report
increas
resist
cultur
cell
diphtheria
toxin
yabrov
yabrov
j
moehr
et
al
boquet
marchenko
et
al
effect
observ
laboratori
stewart
ii
et
al
kohn
et
al
report
interferon
cholera
toxin
interfer
receptor
interact
seem
like
interferon
might
erfer
diphtheria
toxin
manner
though
yabrov
yabrov
yabrov
yabrov
suggest
interferon
act
stabil
cell
perturb
protein
synthesi
demonstr
interferontr
cell
greater
net
neg
charg
cell
surfac
migrat
faster
normal
cell
electr
feld
knight
korant
provid
direct
evid
interferoninduc
cell
surfac
alter
huet
et
al
report
increas
bind
concanavalin
interferontr
cell
increas
slight
hr
reach
maximum
hr
cell
resist
interferon
show
phenomenon
upon
treatment
mous
cell
interferon
follow
observ
surfac
antigen
express
report
increas
cellantibodi
absorb
capac
cell
interferon
sensit
enhanc
express
histocompat
antigen
thymocyt
splenic
lymphocyt
young
mice
enhanc
express
histocompat
antigen
cell
similar
stage
cell
cycl
suggest
enhanc
due
concentr
cell
particular
phase
cycl
killand
et
al
skurkovich
et
al
report
interferontr
cell
exert
enhanc
cellmedi
immun
respons
mice
lindahl
et
al
b
also
found
inject
interferon
young
matur
mice
enhanc
histocompat
display
surfac
thymocyt
splenic
lymphocyt
avail
restrict
antisera
specif
determin
complex
mous
lymphocyt
allow
investig
studi
surfac
chang
lymphocyt
interferon
treatment
follow
result
splenic
lymphocyt
display
increas
fourto
eightfold
antigen
increas
ia
antigen
vignaiax
gresser
increas
antigen
expos
mous
cell
increas
ia
antigen
also
report
lonai
steinman
inject
mice
interferon
also
enhanc
display
k
k
k
splenic
lymphocyt
thymocyt
vignaux
gresser
interest
note
interferon
releas
immunocyt
respons
antigen
target
cell
svetmoldavski
et
al
interferon
induc
turn
alter
reactiv
produc
cell
stimuli
chernyakovskaya
demonstr
presenc
crude
mous
interferon
normal
mous
lymphocyt
acquir
killer
activ
target
mous
l
cell
syngen
lymphoid
cell
also
acquir
abil
exert
antitumor
effect
sarcoma
mice
inocul
benzanthracen
chernyakovskaya
slavin
skurkovich
aleksandrovskaya
also
report
stimul
cytotox
activ
lymphocyt
mice
toward
target
cell
follow
administr
interferon
vivo
svetmoldavski
colleagu
also
demonstr
lymphoid
cell
remov
mice
peak
interferon
product
induc
inject
allogen
cell
exhibit
strong
cytotox
effect
nonspecif
target
l
cell
suggest
interferon
may
play
role
mediat
molecul
initi
variou
immun
reaction
demonstr
lymphocyt
sensit
leukemia
cell
treat
interferon
enhanc
cytotox
observ
result
effect
interferon
lymphocyt
target
cell
slavina
svetmoldavski
report
interferon
induc
sensit
l
cell
cytotox
effect
lymphocyt
thu
seem
nonspecif
system
alter
may
target
cell
wherea
specif
system
alter
may
effector
cell
recent
heron
et
al
report
enhanc
killer
activ
human
lymphocyt
human
leukocyt
interferon
treatment
skurkovich
et
al
report
similar
find
enhanc
cytotox
human
lymphocyt
interferon
exposur
toward
cell
lymphoblastoid
line
also
report
interferontr
cell
sensit
action
cytotox
antibodi
skurkovich
et
al
c
phagocyt
activ
macrophag
monocyt
periton
cell
reticuloendotheli
system
could
stimul
interferon
induc
significantli
higher
level
huang
et
al
demonstr
increas
per
cent
phagocyt
activ
mous
periton
macrophag
expos
unitsml
mous
interferon
show
increas
activ
could
achiev
sever
differ
prepar
mous
interferon
enhanc
effect
macrophag
could
elimin
treatment
antimous
interferon
antiserum
donaho
huang
domonstr
effect
could
accomplish
interferon
induc
newcastl
diseas
viru
vivo
donaho
huang
enhanc
effect
began
sever
hour
last
hr
imanishi
et
al
observ
lag
enhanc
effect
treat
human
peripher
monocyt
human
leukocyt
interferon
observ
instantan
enhanc
phagocyt
activ
increas
number
phagocyt
cell
also
studi
involv
enhanc
phagocytosi
inanim
particl
latex
bead
colloid
particl
studi
demonstr
enhanc
bacteria
remington
merigan
protozoa
herman
baron
leukemia
cell
gresser
bourali
although
studi
demonstr
increas
phagocytosi
viru
tempt
specul
interferon
could
enhanc
uptak
virion
cell
thu
provid
enhanc
virem
clearanc
infect
anim
khesin
et
al
studi
periton
exud
macrophag
mice
inject
interferon
use
criteria
compar
morpholog
cytochemistri
biochemistri
determin
macrophag
activ
ascrib
activ
effect
interferon
interferon
induc
pyran
copolym
poli
ri
poli
rc
dextran
sulfat
inject
mice
found
effect
enhanc
cytotox
tumor
cell
schultz
et
ai
enhanc
spread
glass
plastic
promin
cytoplasm
granul
rabinovitch
et
al
effect
induc
littl
unitsml
interferon
maxim
unitsml
human
interferon
per
cent
effect
mous
cell
find
implic
interferon
system
determin
yet
anoth
mechan
immunemedi
antitumor
antivir
activ
delayedtyp
hypersensit
dth
inhibit
effect
interferon
first
demonstr
report
mice
inocul
interferon
induc
newcastl
diseas
viru
sendai
viru
statolon
hr
challeng
dth
reaction
picryl
chlorid
paint
ear
show
decreas
swell
four
dose
unit
mous
interferon
administ
either
day
day
challeng
inhibit
dth
reaction
investig
demaeyerguignard
et
al
also
show
affer
arc
dth
respons
primari
sensit
well
effer
arc
inhibit
interferon
mice
treat
interferon
day
sensit
decreas
respons
sheep
red
blood
cell
sensit
agent
similar
result
obtain
use
viral
immunogen
newcastl
diseas
viru
demaey
thu
interferon
inhibit
sensit
express
dth
reaction
either
hapten
tcelldepend
antigen
viru
studi
point
paradox
interferon
activ
interferon
antivir
agent
import
recoveri
viru
diseas
tumor
inhibit
cellmedi
immun
reaction
essenti
defens
certain
viru
diseas
tumor
cell
destruct
may
differ
dose
differ
schedul
interferon
administr
mediat
immun
respons
overal
benefit
anim
effect
interferon
graft
surviv
quit
conflict
one
group
report
enhanc
reject
transplant
graft
anoth
group
report
suppress
allograft
reject
chernyakhovskaya
slavina
skurkovich
et
al
b
report
inject
interferon
prepar
mice
acceler
reject
allograft
repeat
transplant
mice
treat
interferon
first
graft
acceler
reject
secondset
graft
worker
conclud
interferon
given
transplant
enhanc
cellmedi
reject
cerottini
et
al
also
found
interferoninduc
interferon
prepar
exert
inhibitori
effect
multipl
transplant
allogen
spleen
cell
syngen
bone
marrow
cell
irradi
mice
oreilli
et
al
report
lack
suppress
marrow
engraft
two
bone
marrow
transplant
patient
given
daili
dose
unit
crude
human
leukocyt
interferon
hirsch
et
al
report
interferon
could
inhibit
prolif
respons
graftvshost
reaction
mice
could
inhibit
activ
leukemia
viru
concomit
reaction
inject
daili
dosag
lli
unit
interferon
one
day
inject
spleen
cell
led
suppress
graftvshost
respons
mobraaten
et
al
also
found
inject
mice
newcastl
diseas
viru
statolon
suffici
give
serum
interferon
level
unitsml
day
graft
significantli
prolong
allograft
surviv
howev
induc
given
prior
graft
suppress
effect
induc
tiloron
effect
prolong
allograft
surviv
given
oral
also
effect
prolong
skin
heart
allograft
rat
wildstein
et
al
kidney
transplant
dog
wildstein
et
al
demaey
et
al
report
interferon
inject
intraperiton
abl
delay
allograft
reject
across
barrier
also
found
better
interferon
produc
mous
strain
h
exhibit
longer
allograft
surviv
ifi
mous
strain
induc
newcastl
diseas
viru
hirsh
et
al
show
unit
mous
interferon
given
daili
reduc
viru
activ
incid
lymphoma
graftvshost
reaction
mice
reduc
sever
reject
reaction
report
may
reconcil
contrast
result
effect
interferon
graftvshost
reaction
imanishi
et
al
report
rabbit
receiv
corneal
xenograft
reject
suppress
unitsml
interferon
given
one
drop
per
eye
administ
twice
daili
howev
dosag
unitsml
regimen
administr
enhanc
reject
reaction
xenograft
appear
reject
reaction
enhanc
suppress
may
depend
complet
upon
dosag
high
dosag
interferon
suppress
graftvshost
reject
reaction
low
dosag
enhanc
reject
reaction
earliest
report
regard
aspect
interferon
action
claim
effect
mice
anderson
desom
et
al
later
investig
abl
demonstr
interferon
induc
effect
antibodi
product
similar
phenomenon
demonstr
graftvshost
reject
reaction
ie
high
dose
interferon
suppress
product
antibodi
wherea
low
dose
enhanc
antibodi
product
braun
levi
merigan
cowork
demonstr
intraven
inject
interferon
abl
inhibit
primari
secondari
hemolysin
agglutinin
antibodi
respons
depress
synthesi
igm
igg
exert
direct
action
bcell
lymphocyt
chester
et
al
merigan
et
al
merigan
other
unabl
demonstr
effect
thorbeck
et
al
ngan
et
al
report
addit
igm
igg
ige
product
complet
inhibit
rel
low
dose
interferon
unitsml
humor
respons
mice
also
found
modifi
anim
infect
corona
viru
murin
hepat
modif
correl
level
circul
interferon
virelizi
et
al
primari
anamnest
respons
hamster
also
report
suppress
interferon
berencsi
beladi
gratifi
find
seemingli
contradictori
report
effect
interferon
vitro
antibodi
product
follow
pattern
immun
respons
case
bifunctionar
reaction
seen
interferon
action
high
dosag
result
suppress
low
dose
enhanc
gisler
et
al
johnson
et
al
booth
et
al
inhibit
antibodi
respons
spleen
cell
found
concomit
inhibit
growth
spleen
cell
cultur
also
shown
poli
ri
poli
rc
abl
inhibit
primari
antibodi
respons
sheep
red
blood
cell
e
coil
lipopolysaccharid
mous
spleen
cell
johnson
et
al
concanavalin
staphylococc
enterotoxin
also
abl
inhibit
plaqueform
cell
respons
johnson
baron
b
interest
effect
poli
ri
poli
rc
could
neutral
antiserum
type
interferon
wherea
effect
due
concanavalin
staphylococc
enterotoxin
neutral
antiserum
observ
suggest
effect
may
due
either
type
ii
interferon
yet
unidentifi
factor
action
interferon
immunomodul
certainli
new
excit
branch
interferonolog
describ
mani
action
interferon
abil
induc
resist
viru
potenti
use
modif
immun
mechan
obviou
desir
characterist
action
interferon
could
exploit
therapeut
use
patient
need
administ
attain
maintain
maxim
effect
view
differ
effect
observ
high
low
dose
attent
paid
problem
current
philosophi
much
possibl
base
either
limit
avail
restrict
impos
side
effect
interferon
whether
induc
virus
endotoxin
synthet
induc
disappear
rapidli
blood
tissu
anim
exogen
administ
interferon
also
disappear
quit
rapidli
earli
work
includ
inject
dosag
unit
unit
per
anim
inject
rout
intraven
test
anim
either
mice
rabbit
averag
time
circul
interferon
drop
trace
amount
rang
min
min
baron
et
al
finter
subrahmanyan
mim
gresser
et
al
ho
bocci
et
al
one
time
assum
clear
interferon
store
releas
rapidli
preform
materi
declercq
cowork
report
repeat
inject
low
dose
interferon
mice
everi
satur
clearanc
mechan
increas
earli
halflif
circul
interferon
min
nuwer
et
al
claim
interferon
receptor
site
bodi
becam
satur
three
inject
conclud
treatment
viru
infect
passiv
interferon
might
feasibl
subsequ
previous
clear
interferon
could
releas
preform
interferon
inject
cycloheximid
chester
et
al
interferon
given
intraven
exhibit
differ
clearanc
profil
given
intramuscularli
amount
interferon
given
alter
clearanc
rate
higher
dosag
lengthen
durat
found
serum
interferon
given
intraven
profil
serum
interferon
exhibit
biphas
curv
sharp
initi
drop
time
inject
hr
gradual
drop
last
hr
averag
halflif
initi
serum
interferon
drop
min
averag
halflif
serum
interferon
latter
part
curv
hr
intramuscularli
inject
interferon
exhibit
differ
profil
serum
interferon
inject
intramuscularli
like
interferon
set
local
pool
gradual
absorb
circulatori
system
serum
interferon
profil
suggest
possibl
level
gradual
rise
intramuscular
inject
reach
peak
hr
gradual
trail
rate
similar
exhibit
iv
rout
intramuscular
inject
appar
maintain
serum
interferon
higher
level
longer
period
iv
rout
pyhala
pyhala
cantel
cantel
et
al
mogensen
et
al
edi
et
al
edi
et
al
skreko
et
al
cantel
et
al
habif
et
al
emodi
et
al
b
finter
arvin
et
al
harmon
jani
found
poli
ri
poli
rc
protect
rabi
mice
inject
leg
inocul
viru
ineffect
inject
opposit
leg
inject
leg
muscl
contain
significantli
higher
level
interferon
leg
strander
et
al
report
advers
sideeffect
patient
rain
intraven
inject
interferon
bodi
weight
sideeffect
includ
nausea
fever
increas
blood
pressur
puls
rate
vomit
sever
shiver
symptom
decreas
hydrocortison
inject
patient
normal
hr
later
subsequ
studi
patient
receiv
interferon
via
intramuscular
inject
sideeffect
inject
fever
ahstrom
et
al
jordan
et
al
desmyt
et
al
studi
perform
test
effect
bloodbrain
barrier
interferon
analysi
serum
circul
interferon
test
anim
inject
interferon
andor
interferon
induc
variou
part
central
nervou
system
revers
experi
ie
inject
interferon
either
intramuscularli
intraven
analyz
interferon
cerebrospin
fluid
anim
test
includ
mice
hamster
rabbit
monkey
human
site
inject
includ
cerebrum
theca
vertebrali
cisterna
magna
later
ventricl
directli
cerebrospin
fluid
lumbarspin
induc
includ
poli
ri
poli
rc
blue
tongu
viru
rabi
viru
sendai
viru
kono
ho
ho
ke
cathala
baron
jameson
et
al
stewart
ii
sulkin
allen
cochran
ho
et
al
habif
et
al
hilfenhau
et
al
overwhelm
agreement
among
studi
report
encourag
interferon
remain
local
except
intraven
inject
inject
site
area
bloodbrain
barrier
effect
allow
passag
small
per
cent
blood
interferon
cerebrospin
fluid
clearanc
cerebrospin
fluid
found
rate
label
albumin
indic
nonspecif
clearanc
addit
bloodbrain
barrier
lubi
et
al
lubi
et
al
found
appear
compartment
interferon
differ
level
differ
area
brain
least
two
viral
enceph
st
loui
enceph
western
equin
enceph
studi
point
compart
barrier
restrict
gener
distribut
interferon
within
bodi
placenta
prove
effect
barrier
interferon
even
induc
inocul
uteru
overal
glasgow
korsantiya
smorodintsev
schafer
et
al
view
cellmultiplicationinhibitori
effect
interferon
placent
barrier
interferon
extrem
import
welfar
rapidli
develop
fetu
studi
indic
interferon
restrict
migrat
blood
stream
aqueou
vitreou
humor
eye
either
direct
oh
gill
pollikoff
et
al
weissenbach
et
al
other
report
contrari
interferon
inject
subconjunctiv
detect
conjunctiva
serum
moder
level
interferon
also
found
collater
eye
equal
level
aqueou
vitreou
humor
intramuscular
inject
interferon
seem
benefici
patient
suffer
herp
kerat
kobza
et
al
result
suggest
free
passag
interferon
circulatori
system
tissu
distribut
seem
account
slight
drop
interferon
activ
local
product
inject
possibl
role
renal
clearanc
tissu
degrad
suggest
report
interferon
inject
rabbit
partial
pass
urin
account
per
cent
inject
interferon
ho
calcul
renal
clearanc
virusinduc
endotoxininduc
interferon
occur
differ
rate
probabl
due
differ
molecular
weight
ho
ho
number
report
describ
fate
inject
interferon
gresser
et
al
bocci
et
al
bocci
et
al
bocci
et
al
b
emodi
et
al
b
cesario
till
report
human
interferon
inactiv
urin
probabl
make
difficult
accur
account
amount
interferon
loss
via
rout
patient
mump
waddel
et
al
viru
infect
bucknal
et
al
found
high
level
serum
interferon
detect
urin
interferon
may
seem
contradict
result
could
reconcil
manner
studi
normal
anim
inject
interferon
benefici
function
healthi
anim
henc
subject
remov
normal
bodi
wast
elimin
mechan
latter
report
patient
suffer
viru
infect
interferon
induc
serv
function
given
intric
balanc
control
within
bodi
unlik
activ
viru
infect
superflu
interferon
produc
necessit
remov
via
renal
clearanc
sever
investig
attempt
modifi
clearanc
interferon
alter
carbohydr
moieti
treatment
interferon
investig
glycolyt
enzym
result
alter
rate
clearanc
bose
hickman
bocci
et
al
bridgen
et
al
mogensen
et
al
major
data
suggest
modifi
carbohydr
moieti
interferon
lead
rapid
clearanc
liver
studi
differ
form
nativ
interferon
interferoid
need
ascertain
fate
interferon
vivo
prolong
circul
interferon
desir
safe
guess
even
know
circul
interferon
mean
transport
diseas
infect
loci
deport
via
elimin
organ
liver
kidney
etc
level
circul
interferon
healthi
anim
diseas
anim
mean
thing
current
trend
interferon
therapeut
base
pharmacolog
antibiot
administr
ie
much
bodi
toler
long
bodi
toler
approach
call
improv
even
philosophi
administ
interferon
harm
effect
patient
cost
interferon
product
necessit
effici
use
given
multifacet
action
interferon
hard
imagin
prolong
high
dosag
undesir
effect
patient
entri
viru
bodi
initi
protect
reaction
mechan
interferon
cellmedi
immun
respons
antibodi
nonspecif
reaction
interferon
probabl
produc
suffici
amount
prevent
infect
primari
portal
entri
first
cycl
viru
replic
like
nearli
current
cost
product
human
leukocyt
interferon
approxim
per
unit
patient
requir
dose
sever
million
unit
per
day
hand
penicillin
averag
daili
oatient
dose
cost
complet
interferon
produc
usual
requir
sever
hour
interferon
produc
respons
initi
invad
must
induc
antivir
resist
cell
contact
also
requir
sever
hour
may
becom
develop
second
third
gener
virion
partial
arrest
progress
destroy
cell
thu
antivir
action
interferon
like
effect
arrest
viral
infect
primari
portal
entri
consequ
primari
viru
infect
abl
becom
establish
portal
entri
local
inflammatori
reaction
consist
leukocyt
accumul
acid
fever
hypoxia
attribut
tissu
damag
caus
viru
replic
may
result
immunemedi
interact
cell
snyderman
et
al
may
turn
relat
releas
interferon
area
indirectli
enhanc
histamin
releas
ida
et
al
induct
prostaglandin
e
yaron
et
al
elev
hormon
level
increas
suscept
anim
viru
infect
relat
partli
interferon
inhibitori
influenc
hormon
kilbourn
et
al
demaey
demaey
smart
kilbourn
rytel
kilbourn
tala
stoger
true
involv
interferon
determin
ff
specif
block
interferon
action
achiev
involv
endogen
interferon
natur
resist
viru
diseas
demonstr
use
antibodi
prepar
interferon
fauconni
fauconni
demonstr
inocul
mice
antiinterferon
antibodi
infect
semliki
forest
viru
lead
earlier
onset
diseas
increas
mortal
gresser
et
al
b
demonstr
involv
interferon
mice
infect
encephalomyocard
viru
use
potent
antiserum
mous
interferon
pathogenesi
antiserumtr
mice
entir
differ
diseas
develop
normal
mice
infect
mice
herp
simplex
antiinterferon
antibodi
acceler
diseas
develo
increas
infect
viru
stock
sever
hundredfold
lethal
doseml
viru
stock
antibodi
also
caus
earlier
appear
moloney
sarcoma
viru
tumor
becam
larger
present
longer
control
mice
tumorinduc
effici
viru
stock
also
increas
antiserum
shorten
incub
period
mice
inocul
vesicular
stomat
viru
alter
influenza
viru
infect
data
clearli
demonstr
earli
role
endogen
interferon
respons
viru
resist
primari
viru
diseas
appar
interferon
abl
offer
protect
anim
primari
viru
infect
without
involv
antibodi
would
interest
determin
role
interferon
immun
anim
use
antiinterferon
serum
might
possibl
observ
role
antibodi
alon
without
interferon
involv
role
interferon
viral
pathogenesi
necessarili
antivir
mechan
interact
immun
system
influenc
defens
mechan
anim
interferon
product
correl
infecti
outcom
viru
infect
immunodefici
anim
subrahmanyan
vilcek
craighead
consid
case
infect
outcom
could
determin
interferon
act
alon
also
adjunct
immun
mechan
obviou
involv
interferon
immun
system
discuss
earlier
includ
increas
cytotox
antibodi
lymphocyt
enhanc
phagocytosi
macrophag
activ
enhanc
antibodi
respons
involv
could
also
explain
find
vitro
sensit
viru
interferon
antivir
action
necessarili
correl
vivo
sensit
viru
interferon
action
vaccinia
viru
quit
resist
interferon
action
rabbit
cell
cultur
youngner
et
al
found
affect
rabbit
interferon
rabbit
skin
isaac
westwood
rabbit
eye
cantel
tommfla
oh
yoneda
herpesviru
quit
insensit
interferon
mani
vitro
system
appear
sensit
eye
meyer
kruger
found
revers
order
sensit
virus
interferon
induc
statolon
poli
ri
poli
rc
vivo
compar
sensit
vitro
observ
support
interpret
interferon
action
vivo
restrict
antivir
action
alon
includ
myriad
multipl
interact
host
defens
mechan
first
report
interferon
activ
varieti
virus
vitro
overtli
toxic
anim
numer
studi
undertaken
investig
effect
interferon
prophylact
therapeut
use
anim
often
difficult
interpol
result
differ
sourc
mani
variabl
studi
interferon
dosag
rang
million
unit
dose
challeng
viru
vari
enorm
time
interferon
administr
rang
viru
infect
late
stage
diseas
rout
viru
interferon
administr
vari
variabl
report
sever
anim
speci
gener
conclus
survey
literatur
interferon
effect
varieti
viru
infect
anim
test
usual
effect
administ
earli
higher
dosag
better
protect
induct
endogen
interferon
anim
usual
found
effect
exogen
interferon
tabl
vivo
action
exogen
interferon
endogen
induc
list
relat
sever
differ
type
viral
diseas
interferon
induc
basic
common
drawback
toxic
hyporespons
interferon
repeat
induct
princip
among
spectrum
toxic
effect
anim
pyrogen
suggest
finter
finter
b
finter
worthington
et
al
baron
et
al
baron
et
al
desom
glasgow
glasgow
habel
rabbit
ermolieva
furer
finter
oh
gill
ho
et
al
postic
fenj
vieuchang
b
cantel
tommila
chani
cerutti
b
herp
adenoarabinosid
lerner
bailey
poli
ri
poli
rc
endotoxin
pyran
induc
damag
cell
membran
releas
pyrogen
along
interferon
lymphokin
braun
tempt
specul
mani
toxic
manifest
sideeffect
attribut
induc
may
mediat
interferon
induc
present
possibl
prove
mani
advers
effect
seen
administr
interferon
date
close
resembl
seen
induc
date
possibl
administ
exogen
interferon
amount
suffici
match
maintain
sever
hour
induc
exogen
interferon
rapidli
clear
circul
high
level
interferon
administ
prolong
period
toxic
lethal
caus
wast
seem
like
reason
interferon
induc
rather
constitut
mechan
antitumor
activ
interferon
appar
depend
type
tumor
involv
time
administr
possibl
amount
interferon
use
mechan
inhibit
two
type
tumor
discuss
separ
tumorigen
potenti
virallyinduc
neoplasm
correl
directli
viru
inoculum
dose
prolifer
potenti
viru
host
case
report
success
antitumor
treatment
interferon
tabl
induc
tabl
pretreat
anim
interferon
prior
viral
infect
necessari
effect
protect
seem
like
case
inhibit
oncogen
polyoma
viru
rou
sarcoma
viru
atanasiu
chani
strandstrom
et
al
case
interferon
administ
infect
achiev
inhibit
ie
friend
viru
rauscher
viru
leukemia
continu
viru
suppress
would
account
effect
investig
suggest
activ
interferon
rauscher
leukemia
mediat
immunolog
enhanc
tothet
al
b
other
discount
complet
role
interferon
activ
furmanski
et
al
howev
view
complex
interferon
involv
defens
mechan
composit
action
ascrib
interferon
like
action
virusinduc
tumor
case
tumor
develop
transplant
cell
appear
tumor
progress
may
lead
continu
transform
host
cell
tumor
virus
case
antitumor
action
interferon
tabl
induc
tabl
satisfactor
explain
term
antivir
activ
rather
resist
mechan
would
appear
involv
direct
cellmultiplicationinhibitori
effect
enhanc
immunemedi
defens
mechan
involv
tumor
limit
elimin
number
interferon
action
includ
ehnanc
lymphocyt
cytotox
svetmoldavski
chernyakovskaya
ira
yakota
et
al
implic
antitumor
activ
interferon
would
seem
like
composit
interferon
action
key
figur
behind
death
surviv
tumorladen
anim
case
may
action
interferon
alon
antitumor
agent
ie
chemotherapeut
alon
may
insuffici
errad
tumor
limit
attempt
made
combin
therapi
proven
effect
tabl
twenti
year
gone
work
interferon
time
specul
sort
rais
possibl
clinic
use
interferon
recent
year
suffici
amount
human
interferon
becom
avail
even
small
preliminari
clinic
trial
yet
even
limit
trial
interferon
evidenc
potenti
treatment
varieti
diseas
man
list
report
trial
demonstr
antivir
antitumor
efficaci
interferon
present
tabl
scarciti
interferon
clinic
use
led
search
effect
induc
endogen
interferon
induc
shown
antivir
activ
man
includ
inactiv
virus
poli
ri
poli
rc
poli
ri
poli
rc
poli
llysin
propanediamin
howev
clinic
applic
prohibit
problem
induc
toxic
hyporespons
suggest
success
limit
trial
exogen
interferon
clinic
encourag
number
ventur
area
interferon
therapi
trial
patient
osteosarcoma
neuroblastoma
recent
report
underway
use
human
fibroblast
interferon
desom
human
lymphoblastoid
interferon
test
osteosarcoma
bodo
g
person
commun
studi
nonhodgkin
lymphoma
patient
fail
standard
therapi
present
underway
trial
human
leukocyt
interferon
prevent
metastas
patient
lungremov
adenocarcinoma
soon
begin
oettgen
h
person
commun
studi
present
underway
evalu
interferon
therapi
breast
cancer
gutterman
j
person
commun
initi
success
report
merigan
et
al
treatment
herp
zoster
patient
cancer
encourag
result
observ
therapi
breast
cancer
gutterman
j
person
commun
close
seem
year
dark
age
interferonolog
initi
hope
clinic
applic
slowli
realiz
worldwid
increas
interferon
product
anticip
meet
increas
demand
encourag
result
clinic
trial
begin
appear
print
increas
avail
interferon
soon
possibl
clearli
defin
potenti
interferon
antivir
agent
clinic
